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Abstract  
Obtaining regular analysis and data is fundamental for policy makers and stakeholders to 
monitor the development of an economic sector and make the necessary decisions to 
maximise the benefits it generates, be they of economic, social or environmental nature. 
The industrial use of biomass feedstock has the potential to contribute to Europe's 
industrial and economic growth while significantly reducing greenhouse gas emissions, 
other environmental burdens, and resource dependency, through the displacement of 
fossil-based products with bio-based alternatives. To this end, this report contributes to 
quantifying and benchmarking relevant sectors in the so-called European Union 
Bioeconomy, the bio-based industries. It looks both at the past and future of the sector 
by focusing on a list of relevant bio-based products (about 70 chemicals and materials) 
and measuring the total population producing or about to produce these products. The 
report presents the result of a survey, based on a structured questionnaire launched in 
March 2015, of 133 companies constituting the total target population. These companies 
are diversity terms of size and time in the market. Some companies' operations are 
entirely bio-based and for some others bio-based products represent a relatively small 
fraction of their operations. They produce and market commodity and speciality 
chemicals and material goods to a wide range of sectors. Fifty companies completed the 
questionnaire and the bio-based products they are involved with are mostly organic 
acids, polymers (obtained from bio-based monomers) and surfactants. The respondents 
operate about 100 manufacturing plants for bio-based products mainly located in the 
established European chemical industry clusters. They also operate production plants in 
third countries, principally in North America and Asia (China, Malaysia and Singapore). 
The respondents total bio-based product turnovers account for €6.8 billion globally (24 
companies answered) and €1.4 billion in the EU (23 companies answered). Therefore, 
these companies produce and sell globally, testimony of the global nature of the sector. 
The survey identified 20 companies using animal fats and vegetable oils, 19 companies 
using sugar or starch crops, and 11 companies using natural fibres. All respondents are 
positive about the outlook for growth in the industry. The response also indicates a rise 
in company activity since 2011, and there appear to be shifts in products being 
developed and produced, probably as a result of market testing, and technical 
development. 
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Executive Summary 
Obtaining regular analysis and data is fundamental for policy makers and stakeholders to 
monitor the development of an economic sector and make the necessary decisions to 
maximise the benefits generated, be they of economic, social or environmental nature. 
To this end, this report contributes, in a pioneering way, to quantifying and 
benchmarking a relevant economic sector within the so-called Bioeconomy.     
For which sectors of the Bioeconomy is economic data lacking?  
The European Union defines the Bioeconomy in its 2012 Strategy and Action Plan as the 
"production of biological resources and the conversion of these resources and waste 
streams into value added products such as food, feed, bio-based products and bio-
energy". The present report focuses on the production of bio-based products by EU 
industry. The use of biomass feedstock in this specific sector has the potential to 
contribute to Europe's industrial and economic growth while significantly reducing 
greenhouse gas (GHG) emissions, other environmental burdens and resource 
dependency, through the displacement of fossil-based products with bio-based 
alternatives. 
This report is limited to bio-based products because food/feed and bioenergy production 
are already established industries and therefore market data are available from different 
sources (e.g. EUROSTAT and FAOSTAT). At the same time, there are also some bio-
based products for which this type of data already exist and are reported, such as pulp 
and paper; textiles; leather; fur; wood and wicker products; and pharmaceuticals. These 
are therefore not considered in this study.  
There is an important part of an emerging Bioeconomy and bio-based industry for which 
economic data are still very difficult to obtain. This includes the production of bio-based 
chemicals, polymers and fibres. 
What to measure and how to describe the EU bio-based industry? 
The general objective of the study is to provide a description of the current status and 
evolution of the EU bio-based industry based on a list of relevant bio-based products and 
a survey of companies producing or about to produce these products (with turnover or 
employing labour in the EU). The list, which contains some 70 products, was initially 
compiled in a previous study commissioned by the European Commission's JRC and 
further refined and validated by experts in several fora, including a dedicated workshop 
organised by the JRC and E4tech in Brussels on 16th September 2014. The final version 
of the list included 21 bio-based polymers; 18 bio-based organic acids; 16 bio-based 
products used in surfactants, solvents, binders, plasticisers, paints/coatings and 
lubricants; 6 bio-based alcohols; and 10 other bio-based products. 
The specific objectives of the study included when possible the quantification of business 
activity in the EU bio-based industry (e.g. number of companies; their size; number of 
companies producing a given product; turnover; number of employees) and the use of 
biomass in bio-based products. The study also aims to determine the drivers and 
constraints affecting the development of bio-based products, as well as to quantitatively 
and qualitatively compare the EU bio-based industry with key competitor countries. 
Before engaging in the industry survey, the target population had to be identified and 
quantified (i.e. number of companies) following the list of products and using three main 
sources of information (F.O. Licht proprietary database, previous research, and contacts 
with sector organisations like the European Chemical Industries Council and the Bio-
based Industries Consortium). 
The survey targeted the total population of companies using a structured questionnaire 
administered mostly on-line with email follow-up. The survey was launched on 31st 
March 2015 and lasted for a couple of months. The questionnaire, which included more 
than 75 questions, was validated during the above-mentioned workshop and with a pilot 
survey.  
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Size of the target population and survey response rate  
The target population consisted of 133 companies which operate at about 300 sites in 
the EU and have some additional assets outside the EU. They are highly diverse in terms 
of size, products and time in the market. Some companies' operations are entirely bio-
based, whereas for some others bio-based products represent a relatively small fraction 
of their operations. The population includes companies producing commodity and 
speciality chemicals and material goods for a wide range of sectors.  
Fifty companies provided a response to the survey, a response rate of 38%. Not all 
respondents provided a response to each question.     
Description of business activities in the EU bio-based industry based on survey response  
A large majority of the bio-based sector consists of private limited liability companies 
(67% of respondents). Both on the basis of the number of employees located in the EU 
in 2013 and of the annual turnover generated in the same year, most of the respondents 
are categorised as large companies. These employ more than 250 people and have sales 
exceeding €50 million annually. 
As regards bio-based products, 27 companies currently produce or expect to produce 
bio-based polymers by 2020; 26 (companies) organic acids; 19 bio-based alcohols; 14 
bio-based composites; 14 bio-based surfactants; 11 bio-based paintings and coatings; 9 
bio-based lubricants; 7 bio-based binders; 6 bio-based plasticisers; and 4 bio-based 
solvents. In addition, 24 companies indicated that they currently produce or expect to 
produce "other" bio-based products by 2020 that were grouped in the previous 
categories. Within these categories, esters constitute the most numerous product in the 
group (6 companies); followed by hydroxymethyl-furfural (HMF), fatty amines, ethylene 
and ethylene glycol (4 companies each); and isosorbide and ‘other polymer additives’ (2 
companies each).  Other products specified were epichlorohydrin, isoprene, farnesene, 
para-xylene, chelating agents, carbon nanotubes (from ethanol), limonene, 
lignosulphonates, acetaldehyde, ethyl acetate and fatty acid amides. 
Only 24 companies provided data on EU sales turnover of bio-based products. However, 
it is possible to observe that for the majority of these companies, these sales remained 
relatively stable through the 2010-2013 reporting period. However, based on 
information from 26 companies, total sales (fossil and bio-based) increased during the 
same period. When it comes to the future evolution of the industry, 89% of respondents 
expect that bio-based product sales will increase by 2020 (49% expect an increase of 
more than 100%). 
Forty-one companies provided information on 100 bio-based production plants located in 
the EU. The majority are commercial (74 plants, including one dormant plant) and a 
smaller number are pilot (16) and demonstration (10) plants. The largest numbers of 
plants are located in Italy, followed by Germany, France, the Netherlands and Spain. 
Germany has the largest number of commercial (active) plants (16), whereas Italy has 
the largest number of pilot and demonstration plants. Most of the bio-based facilities are 
within or near the EU chemical industry clusters.  
In addition, companies reported on bio-based production facilities located outside the 
EU. These are mainly located in Asia (mainly in China, Malaysia and Singapore) and 
North America.      
Companies were asked about their total number of employees in the EU. Forty-two 
respondents reported a total of 220,056 employees in 2013. It is very difficult to assess 
how many of these are engaged in bio-based activities but the survey showed that 55% 
of respondents have more than 50% of their employees linked to the bio-based 
production. The number of employees engaged in bio-based R&D activities does not 
appear to represent more than 2% of the total number employed in all bio-based 
activities.    
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Relative economic size  
The study attempts to assess the relative economic size of the EU bio-based industry by 
using data on the number of companies included in the target population  (133) 
compared to the entire EU chemical industries sector which consists of some 29,000 
companies. This bottom up approach based on survey data cannot be done when it 
comes to the annual turnover and number of employees due to the lack of full response 
on these two variables. However, previous work estimated that the annual turnover 
relating to bio-based chemicals and plastics in the EU was €50 billion for 2009 as 
compared to the figure of the EU chemical umbrella organization which account for EU 
€527 billion for 2013 (whole EU Chemical sector). Such activities in bio-based chemicals 
and plastics contributed with 150,000 jobs to the EU economy as compared to the 1.9 
million employees of the total EU chemical sector1.  
Use of biomass in bio-based products 
The survey identified 20 companies using animal fats and vegetable oils; 19 companies 
using sugar and/or starch crops; and 11 companies using natural fibres. The most 
commonly used vegetable oils, reported in number of companies using them, are 
rapeseed oil and palm oil, followed by coconut oil, soybean oil and castor oil. The types 
of vegetable oils and animal fats used remained consistent between 2010 and 2013, with 
several new users appearing in 2013. 
The most commonly used natural sugar and starch feedstocks are maize, wheat and 
sugar beet, which are all edible feedstocks. No change in usage of these feedstocks has 
been observed between 2010 and 2013, except that several companies reported 
diversification into sugar and starch feedstocks in 2013. The most commonly used 
natural fibre is wood and the number of users increased between 2012 and 2013. 
Finally, the co-products or intermediates used as feedstock are mainly glycerol, 
bioethanol and chemical pulp.      
Half of all respondents claim that more than 95% of their feedstock is bio-based. In 
general, the survey shows that the proportion of bio-based feedstock in the total 
feedstock used has not changed between 2010 and 2013. However, the majority of 
respondents expect this proportion to increase by 2020. 
Finally, information on the use of domestic feedstock versus imports was provided by 28 
companies, of which almost half source all bio-based feedstocks from within the EU. This 
supply includes a broad range of feedstocks (starch, sugar, vegetable oils, animal fats 
and wood fibre). Five companies declared that they import more than 95% of their bio-
based feedstocks into the EU. These companies use mostly vegetable oils, but also 
glycerol, bioethanol, animal fats and starch crops. This ratio of imported versus 
domestically supplied feedstock has been constant during the period 2010-2013.  
Drivers and constrains affecting the development of the industry 
Target companies were asked to declare and rank the importance of a given list of 
drivers and constraints that affect the development of the EU bio-based industry. The 
most important drivers are economic (including innovation) and directly relate to the 
bio-based product and its contribution to the profitability of the company:  improved 
product competitiveness; improved profitability; and development of innovative 
products. These drivers are followed by improved environmental performance of the 
product. Policy is currently ranked as the least important driver, though could become 
more prominent in the future.  
The main constraints for the development of the bio-based industry are declared to be 
the availability of funds to invest in production capacity; the higher production cost of 
bio-based products as compared to the conventional ones; and high and/or variable 
feedstock prices. The existence of products and/or process patents, or other intellectual 
property issues, and the barriers for achieving product certification, while important for 
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many companies, are ranked lowest on the list of constraints by the surveyed 
companies.   
Comparison with EU competitors 
The study has, for the first time, tried to compare the EU bio-based industry with the 
USA, Canada, China, Brazil and Malaysia, following the recommendation of experts and 
existing reports that point to these countries as leaders in this sector (based on existing 
production capacity; planned production capacity; industrial innovation; the status of 
complementary industries - e.g. biofuels -; and the availability of feedstock). Based on 
desk research, the EU compares favourably to other countries on many important 
indicators, with some limitations in feedstock availability and the current level of 
commercial activity.  
Canada (in 2009) and the USA (in 2008 and 2015) carried out similar surveys of the bio-
based sector, but due to the lack of harmonisation in the definition of the industries, 
scope, indicators measured and methodology followed, direct comparisons are not 
reliable using primary information.   
Limitations and recommendations 
The survey is not able to provide a fully quantitative picture of the status and evolution 
of the EU bio-based industry. This is mainly due to the high number of products and 
their diversity; the amount of data that needs to be collected and the difficulty for the 
respondents to assemble it; and the incomplete response rate. At the same time, it is 
not possible to quantitatively compare the EU bio-based industry with important 
competing countries like the USA, China and Brazil due to the lack of harmonisation in 
the scope and methodologies between the existing country reports. However, the survey 
conducted in this study provides an important first step in a systematic approach to 
quantifying the EU bio-based economy and a good starting point for future surveys 
aiming to provide a fuller picture. 
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1. Introduction  
The use of biomass feedstocks in industry has the potential to contribute to the 
European Union’s (EU) industrial and economic growth while significantly reducing 
greenhouse gas (GHG) emissions, other environmental burdens, and resource 
dependency, through the displacement of fossil-based products with bio-based 
alternatives. This was recognised in the 2012 European Bioeconomy Strategy and Action 
Plan2, which outlined the importance of the Bioeconomy for Europe and the potential to 
contribute to a number of EU priorities and initiatives including Innovation Union, 
Resource Efficient Europe, and moving to a low carbon economy. The Strategy built on 
existing programmes for funding research and innovation, including the Seventh 
Framework Programme for Research and Technology Development (FP7) and Horizon 
2020, and initiatives such as the Lead Market Initiative on Bio-based Products3. 
The Strategy and Action Plan highlighted the need to characterise the size and evolution 
of the bio-based industry within the EU, in order for policy makers and other 
stakeholders to be able to monitor, and help shape or support the future of the industry. 
The Bioeconomy Information Systems and Observatory (BISO) was set up to provide 
regular analysis and data to help monitor the development of the Bioeconomy, to 
provide forward looking tools, and to contribute to future strategy updates. The role of 
the BISO is vital in monitoring and maximising the impact of activities aimed at 
developing markets, and of programmes to increase investment in research and 
innovation, including Horizon 2020, national programmes and Public Private 
Partnerships. Without reliable data, the importance of bio-based industrial products to 
the EU economy will remain uncertain, and their full potential and benefits will not be 
realised. 
Biomass feedstocks are primarily utilised in three main sectors of the economy: food and 
feed, energy, and industry. Reliable statistics are already collected in a number of official 
databases for the volumes and values of the food and feed, and energy markets (e.g. 
EUROSTAT, FAOSTAT). However, little economic data exists for industrial uses of 
biomass, and there are no official European databases in this area. Previous research 
broke down bio-based economic activities into NACE classifications demonstrating the 
multitude of industry sectors that belong wholly or partly to the Bioeconomy4. This 
research mapped and analysed the most relevant databases available for information on 
the Bioeconomy, and revealed that there are no specific statistical data available for bio-
based products, and that it is not possible in infer the amount of bio-based products 
from the available databases, due to there being no linkage between raw materials and 
products. 
Information on the production of materials from biomass feedstocks does exist, but is 
often incomplete, disparate, or not sufficiently detailed.  
Information on the availability and production of crops within EU Member States is 
available from EUROSTAT databases, and various assessments of current and future 
available biomass have been carried out5. Biomass use in the food and feed and 
bioenergy sectors is already well-documented, and therefore information about biomass 
use outside of these sectors could be inferred by further analysis. Several initiatives 
have been undertaken to map the flows of biomass into various markets. Nova-Institut 
estimated the non-wood biomass use in the EU27 in 2007 at 266 million tonnes, of 
which 6% was attributed to material use. These estimates were based on data from 
EUROSTAT and the Directorate-General for Trade6. The Bio-TIC project  has further 
elaborated on biomass material flows in the EU, providing estimates of the use of plant 
oils, sugar and starch crops in the EU in 2013 (http://www.industrialbiotech-
europe.eu/).   
There are a number of databases which can give partial information on the current 
production and market size of the bio-based industry, such as Prodcom and the 
Structural Business Statistics both produced by EUROSTAT.  
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Prodcom is an annual survey for the collection and dissemination of statistics on the 
production of goods in the EU, reporting on production volumes and value. Prodcom only 
refers to production data, and Europroms refers to the combination of Prodcom with 
external trade data, again reporting quantities and value at both EU and Member-State 
level. Previous research illustrated that almost 70 products registered in Prodcom are 
made completely or partly from bio-based fats4. However, Prodcom does not 
differentiate between bio-based and non-bio-based products. In addition, the Prodcom 
database does not include information on enterprises with less than 20 employees 
potentially excluding many small companies and start-ups in the emerging bio-based 
industries. 
Structural Business Statistics (SBS) include data on industry, construction, trade and 
services in the EU for each NACE activity classification. Data available from SBS includes 
employment, salaries, and value added, each broken down by industry, though data for 
some categories is incomplete or estimated. Generally SBS does not include data on 
products as this is covered by Prodcom. SBS includes data on the structure, conduct and 
performance of businesses, reported for the EU-27 and individual Member States, with 
subsets available for European regions and according to the size of enterprises. The 
information contained within SBS is therefore more detailed than national accounts. 
However the NACE classifications do not differentiate between bio-based and non-bio-
based sectors so the information could not provide sufficient granularity with respect to 
the Bioeconomy.  
Overall these databases have limited use for gathering data on the bio-based industry as 
biomass-derived products often form an unspecified fraction of database product 
categories. The lack of a link between information on the origin of the raw materials, the 
amount of industrial bio-based products, and the products they end up in constitutes a 
fundamental problem of monitoring the Bioeconomy. 
There are many publication detailing which companies are developing and investing in 
bio-based products and the stage of development of the products, including IEA 
Bioenergy Task 42 Bio-based Chemicals - value added products from biorefineries7, 
Green building blocks for bio-based plastics8, and Technology development for the 
production of bio-based products from biorefinery carbohydrates—the US Department of 
Energy’s “Top 10” revisited9. However, these reports do not give sufficient granularity or 
the data required to monitor the status and evolution of the bio-based industry.  
There is a clear research need to collect and analyse data on the Bioeconomy in the EU 
in general and on the bio-based industry in particular, in order to understand their 
evolution, support their development and gain from the associated benefits. The 
information collected must be comprehensive, detailed, and based on the current EU 
market situation.  
Previous research has assessed how an EU framework for data collection on the 
economic impacts of the Bioeconomy could be created4. It proposes two methods to 
address this research need. The first is the “bio-based share approach” which proposes 
to use data currently reported within existing EU database categories, calculating the 
bio-based share within these categories. The second proposed method is to build up an 
entirely new statistical database, comprising only bio-based products. The second 
approach may provide more exact information and this it therefore the basis of the 
present study.  
It will take time to implement an EU-wide reporting of Bioeconomy indicators. This study 
therefore provides a first step in addressing the information gap. The general objective is 
to provide a description of the current status and evolution of the EU bio-based industry 
by focusing on a list of relevant bio-based products and with a survey of companies 
producing or about to produce these products (with turnover or employing labour in the 
EU). 
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The specific objectives of the study are to: 
1. Provide a description of the business activity in the EU bio-based industries. 
2. Quantitatively describe the use of biomass in bio-based products.  
3. Determine the drivers and constraints affecting the development of bio-based 
products by the EU industry.  
4. Quantitatively assess the impact of the EU bio-based industry on the EU 
economy.  
5. Quantitatively and qualitatively compare the EU bio-based industry with key 
EU competitor countries. 
A similar need for market information has been identified outside of the EU. However, 
only a few research projects and surveys have been carried out aiming to, for example, 
quantify the value of the Bio-economy, and understand the competitiveness of the 
industries that adopt new bio-related processes and procedures. 
2. Scope  
For the purpose of this study and based on consultation with experts (including members 
of the Renewable Raw Materials group), EU companies are defined as those producing a 
turnover or employing labour in the EU which may have production facilities not only in 
this region but elsewhere as well. 
The Bioeconomy encompasses the production of renewable biological resources and their 
conversion into food, feed, bio-based products and bioenergy. This study is confined to 
the production of bio-based products. The production of food, feed and bioenergy are 
outside the scope of the study as data relating to these sectors is reported under 
existing frameworks and in a number of official databases (e.g. EUROSTAT, FAOSTAT). 
For the purpose of this study, the bio-based industries refer to the production of 
chemicals, polymers and fibres produced from renewable biological resources, excluding 
biofuels.  
Some material products are identified as outside of the scope of this study because data 
relating to these existing industries is reported elsewhere. This includes pulp and paper, 
textiles, leather, fur, wood and wicker products, food and feed additives, and 
pharmaceuticals. Established wood industry products such as rayon, viscose, medium-
density fibreboard (MDF) and oriented strand board (OSB) are therefore out of scope. In 
addition pine chemicals such as rosin, linoleum, and turpentine, which are established 
products derived from crude tall oil, which is a co-product of pulp and paper 
manufacture, are also outside of the scope of the study.  
Also, all chemical substances most commonly used as biofuels are considered out of 
scope, as whilst these products may be used directly in non-fuel applications or may be 
used as an intermediate in the production of bio-based materials, data relating to 
production capacity, volumes, revenue and investment is already reported elsewhere.  
Where these substances are used as inputs to the production of other chemical and 
material products, the derived products are within the scope of this study; for example 
the conversion of ethanol to ethylene. In this case, ethanol is considered as a feedstock 
for the production of ethylene. 
Finished goods and products derived from bio-based products (including formulations 
and material products) are outside of the scope of this study. The study does therefore 
not extend to companies using bio-based chemicals and materials in the next stages of 
the value chain.  
3. Methodology 
The methodological approach employed in this study consisted in the following steps, 
described in detail in the following sections: 
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 Definition of a list of relevant bio-based products within the scope of the study, 
validated through expert consultation. 
 Definition and identification of the target population (EU companies) representing 
the universe of the study.  
 Preparation of a structured questionnaire, validated through expert consultation.  
 Pilot survey to validate the questionnaire and survey procedure.  
 Final survey on the full target population of bio-based companies. 
 Reporting results and analysis. 
 
3.1. Defining the product list  
The list of products in the scope of the present study was drafted based on an earlier 
one included in Annex III of the study Methodology framework for the Bioeconomy 
Observatory4 (Key products for a bio-based database).  This study was commissioned by 
the European Commission and was finalized in January 2015.  Here, the authors used 
the following criteria to define which key products should be on the list: 
 The exclusion of food and feed, energy, pharmaceuticals and traditional, 
established, low innovation industries. 
 The existence of EU production facilities at greater than R&D/pilot scale, i.e. those 
products made at near-commercial or commercial volumes within Europe. 
For the purpose of the present study, this initial list of products was reworked and again 
several times consulted with experts and stakeholders including on a workshop that was 
held in Brussels on 16th September 2014. Twenty-one invited delegates attended. During 
the workshop, no products were removed, and some products were added. Some of the 
categories were modified to allow respondents to improve accuracy and remove 
unnecessary restrictions to the scope: building blocks were removed as not all of the 
products included under this category are used as monomers or intermediates for other 
chemical products, this was replaced with organic acids, alcohols, and other; materials 
and composites were edited to composite materials; and paints, lacquers and coatings, 
surfactants, and lubricants were grouped under the heading ‘bio-based products used in 
the following applications’, in order to differentiate between the ‘named’ products and an 
application based list, this also includes bio-based products used in a broader range of 
applications to be included, for example as a solvent in pesticide products.   
No appropriate representative of the pesticides industry was present to comment on the 
inclusion or exclusion of biopesticides, although nova-Institute indicated that in previous 
research surfactants were identified as the most important component of pesticide 
products, from the perspective of bio-based ingredients. These are now included as a 
more general category in the revised list. Biopesticides refers to microbial and 
biochemical active ingredients for use in pesticide applications. Microbial biopesticides 
are derived from various microorganisms including bacteria, fungi, viruses and protozoa, 
and/or the metabolites they produce. Biochemical pesticides are naturally occurring 
substances that typically control pests via non-toxic mechanisms. They include plant 
extracts and pheromones, and also synthetic compounds that are structurally and 
functionally similar to naturally occurring substances. Whilst biotechnology is playing an 
important role in the production of more targeted active ingredients, the conversion of 
biomass to pesticides is not reported as a significant area of research and development. 
It was therefore felt that the survey, being focused on the production of chemical and 
material products from biomass, was not relevant to the sector. 
In addition to the edits highlighted above, rayon was raised as a product with a large 
number of EU producers, however, there are existing market reports relating to the 
industry. The addition of more broad uses of pine chemicals was also raised, however, 
these applications fall outside of the initial scope as outlined in the technical specification 
for the study.  
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The full final list of products is presented in Annex I and includes the following product 
categories: 
• Organic acids 
• Alcohols 
• Polymers: 
o Derived from natural polymers 
o Derived from monomers 
• Composite materials 
• Bio-based products used in the following applications 
o Surfactants 
o Solvents 
o Binders  
o Plasticisers 
o Paints/coatings 
o Lubricants 
• Other products not included in the previous categories 
Figure 1 below illustrates the specific products included in the scope of this study within 
the corresponding value chain. 
 
  
 
Figure 1: Products in the scope of the study and their value chains
  
3.2. Building a database of companies in the EU bio-based 
industries 
The target population was identified using three main sources of information. Firstly, 
information on bio-based chemical industry plants was obtained from the F.O. Licht 
proprietary database. Using information on the name and location of each plant, desk 
research was carried out to identify: 
• Parent company name 
• Operating company name 
• The identity of any joint venture partners or major shareholders/investors 
• The status of the facility, i.e. whether the location specified serves mainly as:  
o a company headquarters (office); 
o production factory site; 
o predominantly a research and development site; or 
o a demonstration plant. 
• Location: 
o Country 
o City / Region 
• Product category and types, including rudimentary information relating to the types of 
product produced, (e.g. oleochemicals, polymers, organic acids, composite materials, 
etc).  The information obtained in this way is often limited due to the information made 
publicly available and the varied operations of many operators. However, the information 
serves primarily to ensure adequate coverage of the target population across product 
sectors. 
• Company website; 
• Company or site address and telephone number; 
• Contact details, including 
o Name,  
o job title,  
o telephone number,  
o email address. 
Additional companies were identified from a number of sources, including previous 
research4 and information from producer organisations including the European Chemical 
Industries Council (Cefic) and the Bio-based Industries Consortium (BIC).  
One-hundred and fifty-one (151) companies was the first estimate of the target 
population (see Table 1). Companies were contacted directly to identify appropriate 
contacts for distribution of the survey questionnaire. Further investigation through desk 
research and following up direct leads facilitated the identification of parent or holding 
companies, as well as the identification of companies which had merged with others, 
ceased operations at particular sites, become insolvent or were identified as ‘out of 
scope’, i.e. not operating within the EU or producing products which fall outside the 
scope of this study (18 companies). 
3.3.  Drafting the questionnaire 
The initial questionnaire was adapted from the same study above-mentioned,   
Methodology framework for the Bioeconomy Observatory4. This was adapted to the 
format of a structured questionnaire to be administered using internet based survey 
software (SurveyMonkey) and an Excel sheet.  
The initial questionnaire was amended through expert consultation during above-
mentioned stakeholder workshop of 16th September 2014 and the feedbacks received 
  
during the pilot survey (see next section). The final questionnaire, used in the survey is 
provided in Annex II. 
3.4. Pilot survey 
A pilot survey was launched on 14th November 2014 to 20 companies out of the initial 
151 previously indicated.  
In order to meet the initial requirements of the study, a two phase survey process was 
designed, in which an on-line survey was supplemented by the submission of other 
questions in an Microsoft excel filed (tailored-part of the questionnaire) sent out to 
survey respondents to gather specific information relating to individual products.  
In total, 7 responses to the online survey were submitted, of which two were incomplete 
with insufficient data provided to facilitate analysis. Thus the final response rate to the 
online pilot survey questionnaire was considered to be 5 responses (response rate of 
25%) and two companies indicated that they did not wish to participate. 
Five phase 2 question sets were subsequently sent out and three responses were 
received, of which one was complete; one incomplete with insufficient data provided to 
facilitate analysis; and one was a specific response indicating that the respondent did not 
wish to participate.  
Specific requests for feedback on the survey and questionnaire were made by phone and 
email. This included both companies that did respond to the questionnaire and those that 
did not. In addition, informal feedback comments were noted when contact was made 
with companies throughout the survey period while trying to generate responses to the 
survey, i.e. follow-up telephone calls to check contact information, receipt of emails, and 
general reminders. 
The main comments received related to concerns over: 
• Time required to complete the survey; 
• Confidentiality / commercial sensitivity of data requested; 
• Unwillingness to take responsibility for providing information (e.g. in case of 
repercussions) or to delegate this responsibility 
• Unclearness for certain respondents about the aims and objectives of the 
survey. 
 
3.5. Final survey 
Feedbacks from respondents to the pilot phase were taken into account to improve the 
survey strategy and the increase the response rate, in particular by improving 
stakeholder engagement, providing assurance regarding the confidentiality of the 
information supplied, and reducing the time and resource required to complete the 
survey. The communication approach in the survey invitation was improved, some 
amendments were included to improve the survey protocol and the survey questions 
were revised in order to enable the full questionnaire to be completed online in one 
stage. Specifically, questions that generated a relatively low response rate were 
removed. Additionally, the questions that were directed to a product-specific basis were 
included in the same questionnaire where respondents were requested to quantify the 
data on the basis of all bio-based products (in-scope) produced by the company. 
The final version of the revised questionnaire was administered to the whole target 
population on the 31st March 2015. 
Out of the 133 companies addressed, 61 reacted when receiving the questionnaire. 
However, 11 of those indicated their unwillingness to participate to the survey (due 
mainly to confidential issues) and 50 participants provided the data, giving an overall 
response rate of 38% (Table 1). The group of 50 also includes participants that provided 
their answers during the pilot phase of the survey and others that sent their data per e-
  
mail, i.e. not completed as required by the questionnaire. Therefore, the figures reported 
in the results do not represent the whole group of 50 companies but the participants who 
have provided data for each specific question. Most of the respondents did not answer all 
questions.   
Table 1: Response rate description in the survey to the EU bio-based industry 
Initial population 151 
Out of scope*  18 
Final population 133 
Total responses received 61 
          of which positive 50 
          of which negative** 11 
Response rate (of positive responses) 38% 
Note: *subsequently discovered through responses and contact, **refusal to participate to the survey 
Similar surveys in the United States and Canada have taken an, a priori, comparable 
approach. Statistics Canada’s Bioproducts Production and Development Survey 2009 
targeted all companies in Canada that use renewable feedstocks to develop or produce 
industrial bioproducts10. The survey identified 208 companies engaged in the production 
or development of bioproducts of which 59% responded. The United States International 
Trade Commission’s Study on Industrial Biotechnology: Development and Adoption by 
the U.S. Chemical and Biofuel Industries distributed 1,800 questionnaires to chemical 
and liquid fuel producers and achieved a response rate of 67%11. The results of these 
surveys are taken into consideration in this study for benchmarking with the EU results. 
4. Results 
The results of the study are presented and discussed in the following sections. In 
addition, Annexes III and IV detail the results of the survey.  
4.1. Description of the population 
As illustrated in Table 1, the initial target population consisted of 151 companies 
operating in the bio-based industries and invited to participate in the survey. These 
companies control at least 300 subsidiary companies and factory sites in the EU and 
some have additional assets outside the EU. Of the 151 companies invited to participate 
in the survey, 18 companies failed the screening questions which were designed to 
disqualify companies ‘out of scope’, i.e. not producing one of the specified list of 
products, and/or not employing staff in the EU. After this, the final target population 
comprised 133 companies.  
The target population includes small, medium and large enterprises; long established 
companies and new companies; and companies whose operations are entirely bio-based 
and those for whom bio-based products represent a relatively small fraction of 
operations. It includes companies producing commodity and speciality chemicals and 
material goods into a wide range of sectors. Due to the diversity of the target population 
and the relatively small number of companies, it is appropriate to take a census 
approach to survey the target population, requesting a response from each individual 
company. 
As it will be shown in the following sections, the location of the majority of bio-materials 
facilities seems to occur within or near the European chemical industry clusters 
illustrated in Figure 6. The chemicals industry in Europe is largely characterised by these 
  
clusters of activity, as being located near other chemicals companies enables easier 
access to specialised suppliers and service providers, and can facilitate industry learning 
and ideas-sharing12. These benefits also apply to the bio-based products industry, as 
established chemicals companies are able to apply innovative solutions to move existing 
operations towards greater utilisation of bio-based feedstocks. In addition, start-up 
companies in the bio-based products sector are likely to benefit from the infrastructure 
and knowledge-base available in existing chemical industry clusters. As with the 
European chemical industry, it will be seen that the location of production plants for the 
bio-based industry is concentrated around the three main European ports of Rotterdam, 
Hamburg and Antwerp.  
Production facilities in northern Denmark, Sardinia, Bulgaria and southern England 
appear to have been developed without the support of existing chemical industry 
infrastructure, suggesting that the bio-based industry can expand beyond the 
geographical scope of the European fossil-based chemicals industry. 
 
 
Figure 2: Location of major chemical parks in Europe. Colours: grey – no ECSPP members on park, 
orange – ECSPP members on park 
Source: European Chemical Site Promotion Platform (ECSPP) 
 
4.2. Description of the sample 
Mimicking the description of the population, responses were received from a range of 
company types including large, medium and small enterprises; long established 
companies and new companies; and companies whose operations are entirely bio-based 
and those for whom bio-based products represent a relatively small fraction of 
operations. However, due to the diversity of the target population in terms of company 
size, products, and market sectors, and the relatively small number of companies from 
  
the target population that responded to the survey, it is not appropriate to extrapolate 
the survey responses to the full population size.  
Regarding the companies' structure, 48 companies provided information on the 
ownership structure of the company, of which 32 companies are private limited liability 
companies, 15 companies are public limited companies, and 1 company identified as a 
not-for-profit organisation. 16 of the 48 companies identified as subsidiaries of larger 
companies, and 5 identified as a joint venture (between two or more companies).  
In the EU, organisations may be categorised based on the number of employees or 
annual revenue. The European Commission defines micro, small, medium and large 
enterprises on the basis of the number of employees as follows: 
• A microenterprise is defined as an enterprise which employs fewer than 10 persons. 
• A small enterprise is defined as an enterprise which employs fewer than 50 persons. 
• A medium-sized enterprise is defined as an enterprise which employs fewer than 250 
persons. 
• A large enterprise is thus assumed to employ more than 250 people. 
In total 42 companies provided information on the number of employees in 2013. On 
this basis, 22 large enterprises were identified in the survey, 9 medium enterprises, 6 
small enterprises, and 5 micro enterprises. Large companies are the biggest group but it 
is also heterogeneous, including 8 companies with <1000 employees, 5 companies with 
between 1001 and 5000 employees and 9 companies with more than 10,000 employees 
(Figure 3). 
 
Figure 3: Types of respondent companies based on number of employees within the EU, between 
2010 and 2013 
Source: EU bio-based industries survey 
Alternatively, the European Commission defines micro, small, medium and large 
enterprises on the basis of annual sales revenue as follows: 
• A microenterprise is defined as an enterprise whose annual turnover does not exceed €2 
million. 
• A small enterprise is defined as an enterprise whose annual turnover does not exceed 
€10 million. 
• A medium-sized enterprise is defined as an enterprise whose annual turnover does not 
exceed €50 million. 
  
• A large enterprise is thus assumed to have an annual turnover exceeding €50 million. 
The EU bio-based industries survey collected information on the total annual sales 
turnover of the companies in the EU, and the bio-based products annual sales turnover 
worldwide. In total 26 companies provided information on the total sales turnover in the 
EU in 2013. On this basis, 16 large enterprises were identified, 1 medium enterprises, 2 
small enterprises, and 7 micro enterprises (including 4 companies who indicated sales 
revenues of zero) (Figure 4). 
 
Figure 4: Types of companies based on annual turnover of all products in the EU, between 2010 and 
2013 
Source: EU bio-based industries survey 
In summary, the distribution of company's size and structure seems to be 
heterogeneous enough to consider the sample as representative of the whole population.  
Geographical distribution of companies in the sample is detailed in the following sections. 
Countries with the strongest bio-based activities in place like Germany, the Netherlands 
and Italy are well represented and the rest of companies are distributed in different 
countries. Therefore, the sample is kind of representative in terms of geographical area 
covered.   
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4.3. Description of the business activity in the EU bio-based 
industries 
Products  
The survey collected information from all the 50 companies on the types of products 
produced or expected to be produced by 2020. As reported in Figure 9, the bio-based 
products indicated by most respondents are organic acids, polymers (obtained from bio-
based monomers) and surfactants. This figure shows in one picture the products that are 
currently in the market and/or expect to be by 2020. If we compare the products 
currently produced with the ones expected to be produced in 2020, there is a general 
growing trend in terms of number of products, but not concerning all of them (see Annex 
III for detailed analysis).  
 
Figure 5: Number of times companies report they currently produce and/or expect to produce bio-
based products by 2020 
Source: EU bio-based industries survey 
Note: 50 respondents. In this figure each specific organic acid, for example, counts one. 48 organic different 
organic acids are currently produced or will hit the market by 2020. Figure A25 of Annex III, all organic acids, 
for example, indicated by the same company count as one.  
If we count both the currently produced and the expected bio-based products, 284 
products have been indicated in total by the 50 respondents (i.e. between 5 and 6 per 
company in average). While some companies only indicated 1-2 products, others 
indicated up to 20 products, and often belonging to different product categories. This 
variety makes the overall data analysis very complex, since most indicators have been 
asked for the whole bio-based sector within the company, and not specifically per 
product. 
The most frequently indicated products, mostly chemicals, are illustrated in Figure 6, 
which presents the number of companies that currently produce or expect to produce the 
product by 2020. This includes a range of speciality (or functional) chemicals, 
oleochemicals, polymers, and chemical building blocks. Many of these are established 
products, such as fatty acids and fatty acid esters, paint additives, polymeric surfactants, 
starch polymers, and wood–plastic composites. However, a number of these products 
currently have few producers, but more companies report that they expect to begin 
production by 2020. For PBS and HMF, no current producers were identified but four 
companies indicated they expect to produce by 2020. For FDCA and PHAs, two 
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companies indicated that they currently produce these products, and five companies 
indicated that they expect to produce these products in 2020. In addition, three 
companies expect to begin production of levulinic acid, n-butanol and propylene glycol 
by 2020.  
 
Figure 6: Bio-based products most frequently indicated by the survey respondents  
Source: EU bio-based industries survey 
A detailed breakdown of the individual products is provided in Annexes III and IV, while 
here we discuss the trends.  
Figure 7 ranks the type of organic acids that are most commonly produced or expected 
to be produced by 2020. 23 companies currently produce or expect to produce fatty 
acids of various types; however the survey did not collect information on the expected 
evolution of fatty acid production to 2020. The most common products stearic acid, oleic 
acid, and palmitic acid are produced by the saponification of vegetable oils and animal 
fats and used in the production of soaps, cosmetics, detergents, and release agents.  
Other organic acids include succinic acids, FDCA, and levulinic acid. These chemical 
building blocks are all expected to see an increase in the number of producers to 2020, 
though the production of these bio-based products is not yet at full commercial scale 
globally. There are several succinic acid producers in the EU and the rest of the world, 
increasing production capacity to near commercial scale. The product is a drop-in 
replacement for petrochemical succinic acid and adipic acid in some applications, and is 
used in the production of resins, plasticisers and biodegradable polymers. Production 
routes for FDCA are at pilot scale, but several technology developers expect to increase 
production capacities. The largest market for FDCA is the production of PEF, which may 
substitute for PET. PEF is more than a substitute for PET as it has superior properties, 
but may be used in existing polymerisation units, and therefore has the benefits of a 
drop-in product. Production processes for levulinic acid are at demonstration stage and 
production capacities are expected to scale up to 2020. Bio-based levulinic acid may 
substitute the petrochemical product for use in food, pharmaceutical, and personal care 
applications. For each of these leading products, the industry expectation is that the 
development of the bio-based routes will lead to market growth and an increasing range 
of applications. Production of a number of other products, whose bio-based production 
routes are at pre-commercial stages of development, is expected to increase in the EU, 
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including acrylic acid, terephthalic acid, and methacrylic acid. Decrease in production 
activity is expected for lactic acid and acetic acid, bio-based products that are produced 
at full commercial scale globally. The survey indicates an expected increase in the 
number of bio-based organic acids to 2020, and this is consistent with industry activity 
in Europe and the rest of the world and the number of new bio-based production routes 
in development13.  
 
Figure 7: Number of companies that currently produce and/or expect to produce organic acids by 
2020 
Source: EU bio-based industries survey.  
Note: * indicates types of fatty acids (23 companies in total). 
Figure 8 ranks the type of alcohols that are most commonly produced or expected to be 
produced by 2020. The most common products are fatty alcohols, n-butanol, PDO and 
propylene glycol. The survey did not collect information on the expected evolution of the 
fatty alcohols. The survey results indicated growth in the number of producers of n-
butanol, PDO and propylene glycol, resulting in a greater number of bio-based alcohols 
in the market. Again, this is reflective of the emerging nature of the bio-based 
production routes to these products 13.  
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Figure 8: Number of companies that currently produce and/or expect to produce bio -based alcohols 
by 2020 
Source: EU bio-based industries survey. 
Of the companies that currently produce or expect to produce bio-based polymers by 
2020, more than 90% currently produce or expect to produce bio-polymers from 
monomers (Figure 9), and 45% currently produce or expect to produce bio-based 
polymers from natural polymers (Figure 10). For this we can see that there is significant 
overlap with many companies producing both polymers from monomers and natural 
polymers. The natural polymers are dominated by starch polymers and this is supported 
by figures from a comprehensive study of the bio-based polymer industry14. In terms of 
production capacity, Europe is a leading producer of starch polymers, and capacity for 
the production of plastics is dominated by starch polymers in Europe and is expected to 
remain so until at least 2020. 
Regarding polymers derived from monomers, the most common products are PHAs, 
polyamides and PLA. Europe is reported as a strong contributor to global production of 
polyamides14, although the survey indicates a reduction in the number of producers to 
2020. PHA and other emerging products such as PBS (which are currently produced at 
demonstration scale) are expected to increase in Europe to 2020. Interestingly whilst the 
number of producers of lactic acid is expected to reduce in Europe to 2020, the number 
of producers of PLA is expected to increase; this may reflect that innovation remains in 
the production of PLA rather than the lactic acid. PHA, PLA and PBS are not used as 
drop-in replacements for petrochemical products; rather their market is linked to certain 
properties such as biodegradability. Trends in the production for plastics in Europe differ 
to the rest of the world, where growth in the last two years has been dominated by 
drop-in products. European Bioplastics estimate that production capacity in Europe will 
continue to increase to 2017, but at a much slower pace than in South America and Asia, 
so that the European share of the market will reduce to around 7%.  
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Figure 9: Number of companies that currently produce and/or expect to produce bio -based polymers 
(derived from monomers) by 2020 
Source: EU bio-based industries survey. 
 
Figure 10: Number of companies that currently produce and/or expect to produce bio-based 
polymers (derived from natural polymers) by 2020 
Source: EU bio-based industries survey. 
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Other products are dominated by surfactants, primarily polymeric surfactants. The 
survey responses indicate that number of producers of polymeric surfactants is expected 
to remain stable to 2020, whilst many of the other surfactant products are expected to 
reduce in the number of producers out to 2020 (see Annexes III and IV for a detailed 
break-down).   
Production facilities  
Forty-two companies reported they have bio-based production facilities in the EU, 7 do 
not and 1 did not answered. Forty-one companies provided information on 100 bio-based 
production plants located in the EU. The majority of these EU-based plants reported 
were commercial plants (74 plants including one dormant plant), and a smaller number 
of pilot (16) and demonstration (10) plants. Figure 11 illustrates the location of the 
production facilities in the EU in terms of country. The largest numbers of plants are 
located in Italy, Germany, France, Netherlands and Spain. Germany has the largest 
number of commercial plants and Italy has the largest number of pilot and 
demonstration plants.   
 
Figure 11: Status and location of bio-based production facilities in the EU 
Source: EU bio-based industries survey. 
Of the survey respondents, 21 companies indicated that they have bio-based production 
facilities outside the EU, of which 18 companies provided information on 41 separate 
plants.  The majority were commercial plants (40 plants including one dormant plant). 
Their location is also shown in Figure 11. The largest number of plants is located in Asia 
and North America. Within Asia, the greatest number of plants was located in China (5), 
Malaysia (3) and Singapore (3). 
Back to Europe, the location of all facilities (headquarters, R&D, demonstration and 
production) obtained via desk research and the survey response for the 133 companies 
is illustrated in Figure 12. The target population of this study shows a similar distribution 
as the main European chemical industry clusters shown in Figure 2. 
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Figure 12: Location of the target population premises within the EU, showing headquarters (red), 
R&D sites (yellow), demonstration plants (blue) and production plants (green).  
Source: EU biobased industries survey 
 
Respondents indicated that the main reasons for choosing the facilities' location are 
related to feedstock availability and to proximity to already existing activities, both 
commercial and R&D, and this is valid both for facilities inside and outside the EU (Figure 
13 and see the detailed answers in Annex III).  
 
Figure 13: Reasons for choosing the facilities' location in the EU and outside the EU (N. of 
respondents: 35 in the EU, 16 outside) 
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Unfortunately, the survey data do not allow us to identify which products are produced 
at which locations. Similarly, it does not allow us to identify which feedstocks are used at 
which locations.  
Production and sales   
The European Commission communication Innovating for Sustainable Growth: A 
Bioeconomy for Europe2, estimated that the European Bioeconomy has an annual 
turnover of €2 trillion, including the agriculture, forestry, fisheries, food and pulp and 
paper industries, as well as parts of the chemical, biotechnological and energy industries. 
The annual turnover relating to bio-based chemicals and plastics in the EU was 
estimated at €50 billion for 2009. It is not possible to verify this estimate based on the 
EU bio-based industries survey due to the incompleteness of the data set. Only 24 
companies provided data on the global sales turnover for bio-based products (€6.8 
billion in 2013), and 23 companies provided data on the EU sales turnover of bio-based 
products (€1.8 billion in 2013).  
Despite the incompleteness of the data set, it is possible to observe the following trends 
for the respondents who provided a complete data set (2010 – 2013). European sales of 
all products (fossil and bio-based) increased from 2010 to 2013, whilst global and EU 
sales turnover for bio-based products remained relatively stable throughout the 
reporting period. Individual company performance over the reporting period may be 
assessed in order to establish any trends (Figure 14). For the majority of companies, EU 
sales of bio-based products have remains relatively stable between 2010 and 2013, with 
a medium and large producers seeing sales reduce. There are examples of high growth 
rates in both small and larger companies, of up to 600%. Two companies display strong 
growth, and they each produce a range of products from different product categories 
(including composites, chemical building blocks, surfactants and binders), these 
companies both utilise wood feedstocks among others. 
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Figure 14: Indexed EU sales turnover for bio-based products, illustrated based on size of production 
Source: EU bio-based industries survey. 
Survey respondents expect future revenues to increase, 89% of companies expect global 
bio-based sales revenues to increase by 2020, with 53% of companies expecting an 
increase in revenues of more than 100%. Similarly, for European sales turnover of bio-
based products, 89% of respondents expect an increase to 2020, including 49% who 
expect an increase of more than 100%. 
Total production of bio-based products in the EU declined between 2010 and 2013 from 
6.9 million tonnes to 6.3 million tonnes, for the limited number of respondents who 
provided data for each year (20 respondents). Individual company performance over the 
reporting period may be assessed in order to establish any trends (Figure 15).  
The large producers display modest growth in EU production of bio-based products, and 
in one case significant decline. Small companies (with production of up to 100 tonnes in 
2010) have demonstrated high growth rates in all cases, and in some cases up to 900%. 
This had been achieved by small enterprises dedicate to the production of bio-based 
products, and large enterprises with extensive petrochemical profiles. 
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Figure 15: Indexed EU production of bio-based products in tonnes, illustrated based on size of 
production 
Source: EU bio-based industries survey. 
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The proportion of EU bio-based output sold within the EU declined between 87% in 2010 
to 82% in 2013, although the majority of companies reported no change in the 
proportion of their products sold in the EU. 
Employment  
The EU bio-based industries survey captures data on a limited number of companies and 
it is therefore not comparable to previous industry wide estimates. Within 43 companies 
operating in the bio-based industries it identified that the total number of employees 
within the EU was over 220,000 in 2013. More than 99% of the total jobs exist within 
large organisations (with more than 250 employees in the EU). Thirty-three companies 
provided an indication of the number of employees working in bio-based activities, with 
a total of 2,334 employees in 2013. Eleven companies stated that 100% of their 
employees were involved in bio-based activities, including several large organisations 
with more than 250 employees. The majority of companies indicated that the percentage 
of employees engaged in bio-based activities was greater than 50% (19 out of 35 
companies) (Table 2), and the majority of the jobs identified are therefore within 
companies in which bio-based activities represent a major share of the business activity.  
Table 2: Proportion of total employees engaged in bio-based activities (No. of companies) 
 Number of companies 
Proportion of 
employees in 
bio-based 
activities 2010 2011 2012 2013 
>50% 11 12 14 19 
25% to 49% 1 1 1 2 
10% to 24% 4 5 4 6 
<10% 10 7 8 8 
Source: EU bio-based industries survey. 
 
Figure 16 shows the trends of number of employees in bio-based activities in the EU. It 
is illustrated that there was an increasing trend in the number of employees employed in 
bio-based activities, with the exception of companies producing more than 50,000 
tonnes of bio-based products. This is comparably with the trends in output and turnover. 
  
  
  
 
 
Figure 16: Trends of number of employees in bio-based activities in the EU. Index = 100 in 2010. 
Companies are classified according to their annual output in tonnes  
Source: EU bio-based industries survey. 
 
Research and Development  
The survey requested an indication of the percentage of employees active in research 
and development, analysis of these results indicates that 3,237 employees working on 
research and development of bio-based products in 2013 within 33 companies. This 
figure is greater than the number of jobs identified in the bio-based industries in the EU, 
due to a different set of respondents, and therefore not comparable. A major challenge 
with data collected on jobs and R&D is that companies producing a range of bio-based 
products in scope and out of scope for the survey, in most cases have not made an 
appropriate estimate for only the products in scope.  
However, again an attempt can be done by illustrating the trend of number of employees 
in R&D activities related to bio-based products as reported by the respondents classified 
in terms of production in tonnes. In general terms, respondents seems to have either 
increase or maintain the number of employees in R&D during the 2010-2013 period, 
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except for companies producing more than 50,000 tonnes which either maintain the 
number or decrease it.   
 
  
 
 
Figure 17: Trends of number of employees in R&D activities related to bio-based products in the EU. 
Index = 100 in 2010. Companies are classified according to their annual output in tonnes  
Source: EU bio-based industries survey. 
The survey did not collect data on private capital investment into bio-based products, 
but did collect information on public funding. 55% of survey respondents indicated that 
they have received public funding since 2010 indicating investment in research, 
development and demonstration. Interestingly 45% of companies indicated that they 
have not received public funding, which indicate that there is a mature, competitive bio-
based products sector, and that public funding is directed at finding the next generation 
of products.  
A total of €120 million of public funding was awarded to respondents between 2010 and 
2013, the total annual awards increased between 2010 and 2013. Responses indicate 
that there are a wide range of national and EU funding initiatives, highlighting the 
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importance of ensuring complementarity and maximising synergies between funding 
programmes. 
Costs 
According to the survey respondents, the average contribution (%) of various cost 
categories to production costs for bio-based products produced in the one shown in 
Figure 18. It illustrates that the biggest determinants of the overall production costs is 
the biomass feedstock, in line with what was stated in the analysis of constraints. 
However, there are large variations between companies and these figures have to be 
considered cautiously.    
 
Figure 18: Average cost distribution for companies over the period 2010-2013 
Source: EU bio-based industries survey. 
4.4. Use of biomass in bio-based products 
According to the participants to the survey, the most used source of feedstock to 
produce bio-based products in the EU is vegetable oils (Figure 19), which can be 
explained by the fact that most products in the list are oleochemicals, like surfactants, 
lubricants and solvents. Nine-teen companies reported they use vegetable oils, 16 starch 
and 14 alcohols. Obviously, the same company can use and combine more than one 
feedstock.    
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Figure 19: Feedstock sources indicated by respondents for the production of bio-based products 
Source: EU bio-based industries survey. 
The survey has not collected information on the quantities of feedstocks used or on 
feedstock use on an individual product basis, due to the large number of products, the 
complexity of the questionnaire, and the ability of respondents to collect specific 
information. It may however, made a number of observations based on the responses. 
The survey has identified 20 companies using animal fats and vegetable oils (there is 
only one user of animal fats that does not also use vegetable oils), 19 companies using 
sugar or starch crops, and 11 companies using natural fibres.  
The most commonly used vegetable oils are rapeseed oil, and palm oil, followed by 
coconut oil, soybean oil and castor oil. All of these products are edible with application in 
the food and feed sectors. Of the 20 companies identified as using vegetable oils and 
animal fats, 18 use edible vegetable oils, 9 use a combination of edible vegetable oils 
and animal fats, and 2 companies specify only feedstocks that do not compete with the 
food industry (algae oils and animal fats) – these companies are both small enterprises 
(fewer than 50 employees), and new bio-based product producers, indicating that they 
started consuming feedstocks in 2013. Whilst the survey has not collected data on the 
volumes of each feedstock used, it appears that companies are consistent in the types of 
vegetable oil and animal fats used between 2010 and 2013; the survey has not identified 
any changes in feedstocks used between years, except in the case of several new users 
of vegetable oils and animal fats in 2013. 
The most commonly used sugar and starch feedstocks are maize, wheat, and sugar 
beet, all edible feedstocks which may compete with the production of food and feed. 
Data on the quantities of each type of feedstock has not been collected, but companies 
seem to be consistent in their use of sugar and starch feedstocks – we have not 
observed changes in feedstocks between 2010 and 2013, except several companies have 
reported diversification of sugar and starch feedstocks in 2013. In total 19 companies 
reported using sugar and starch feedstocks, of which 17 companies use edible 
feedstocks, only 1 company specified that it used only lignocellulosic sugars, and 1 
company uses dextrose. The use of agricultural residues has increased between 2010 
and 2013 although it is not specified if this is lignocellulosic material.  
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The most commonly used natural fibre is wood, and the number of users has increased 
between 2012 and 2013. Companies have generally been consistent in the fibre 
feedstocks which they have used between 2010 and 2013, with the exception of several 
new users which seem to have emerged in 2013. The new users include micro 
enterprises and large enterprises.   
Regarding the use of industry co-products or intermediates, 9 companies indicated they 
use glycerol as a feedstock, 3 of which are micro or small enterprises who have started 
using glycerol in 2012. The survey has also identified 7 users of bioethanol, 2 users of 
chemical pulp as a feedstock for bio-based materials (both pulp and paper companies) 
and no users of biomethanol.  
Information on the use of domestic feedstock versus imports was provided by 28 
companies, of which almost half source all bio-based feedstocks from within the EU, 
including a broad range of feedstocks (starch, sugar, vegetable oils, animal fats and 
wood fibre). 5 companies import more than 95% of their bio-based feedstocks into the 
EU; these companies use mostly vegetable oils, but also glycerol, bioethanol, animal fats 
and starch crops. The majority of companies have been consistent in the ratio of 
domestic and imported feedstocks, notably 2 large producers of bio-based products have 
increased the proportion of feedstock imported into the EU, including glycerol.     
Information on the proportion of bio-based feedstocks in total feedstock use was 
provided by 30 companies, of which almost 50% claim more than 95% of their feedstock 
is bio-based. The profile of these companies vary widely, including micro to large 
enterprises, utilising fermentation, catalytic, and other processes to produce bio-based 
products from starch and sugars, vegetable oils and animal fats, ethanol, glycerol and 
other alcohols. The proportion of bio-based feedstocks in total feedstock use for 
individual companies is largely consistent between 2010 and 2013, and the increase 
illustrated in Figure 20 is due to new producers reporting only for 2012 and/or 2013. 
However, the majority of respondents expect that the proportion of bio-based feedstock 
in total feedstock use will increase to 2020. According to most respondents (68.4%), the 
contribution of bio-based feedstock to total feedstock use is likely to increase by 2020. 
According to the 23.7% of respondents the increase will be higher than 100%. 
  
 
Figure 20: Proportion of bio-based feedstock sourced from within the EU 
Source: EU bio-based industries survey. 
Feedstock availability was cited as a key reason for selecting the location of bio-based 
production facilities in the EU by approximately 50% of respondents, and is the most 
important factor alongside proximity to existing commercial activities. The profile of the 
companies stating feedstock availability as a key location factor vary widely, these 
companies use a broad range of feedstocks, sourced from the EU and imported into the 
EU.  
The data collected by the EU bio-based industry survey does not enable us to quantify 
the total use of bio-based feedstocks in the EU. However, detailed quantitative analysis 
of feedstock use has been carried out for some feedstock types in other projects. The 
Bio-TIC project provides an estimate of the use of plant oils and sugar and starch crops 
for material uses in the EU in 2013. The use of starch and sugar for material uses is 
estimated at 2 million tonnes in 2013, dominated by fermentation products, solvents, 
and starch blends. This compares to annual production of 16.4 million tonnes of 
crystallised sugar for food application, 7.8 million tonnes used in the production of 
ethanol, and 1.5 million tonnes used in paper products. The domestic supply of starch 
crops was estimated at 329 million tonnes in 2013, of which 299 million tonnes were 
used in the production of food and feed, and 22 million tonnes for starch production, to 
supply numerous industries.  
Bio-TIC estimate that 1.2 million tonnes of plant oils were used in production of 
materials in the EU in 2013, including 0.5 million tonnes in paintings and coatings, 0.4 
million tonnes for surfactants, 0.15 million tonnes for lubricants and 0.1 million tonnes 
for polymer production. This compares to 10 million tonnes of plant oils used in the 
production of biofuels, and 13.6 million tonnes in food and feed applications. 
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4.5. Drivers and constraints affecting the development of 
bio-based products by the EU industry 
According to the respondents of the EU bio-based industries survey, the most important 
drivers for the development of bio-based products within the EU are improved product 
competitiveness (with 93% of companies rating this as an important driver), improved 
profitability (89%), sales growth potential (89%), development of innovative products 
(87%), improved product properties or performance (84%), and improved 
environmental performance (82%), as shown in Figure 21. Where respondents were able 
to indicate an unlimited number of drivers, the majority of pre-defined options were 
rated as important by more than 50% of respondents, including potential to increase 
market share, market demand increase, sustainability goals, production related to 
current competencies, availability of public funding, and product diversification. This 
illustrates a diversity of drivers behind bio-based product development associated with 
different value propositions and the potential to innovate.  
 
Figure 21: Ranking the most important drivers for the development of bio -based products 
Source: EU bio-based industries survey. 
The response from the EU bio-based industries is in close agreement to the most 
important reasons for evaluating or pursuing Industrial Biotechnology, from companies 
surveyed in the US, specifically the most important reasons identified were to improve 
profitability, sales growth potential, and to improve competitiveness11. In Canada, the 
most important factors which influence the development of bio-based products cover 
similar themes, although the relative importance of these factors differs from the EU and 
US results. In the Canadian survey, respondents associated greater importance to 
increasing product range (74% of respondents) and less companies associated bio-based 
products with improved economics (38% of companies stated using biomass to reduce 
production costs)10.  
According to respondents of the EU bio-based industries survey, the most important 
constraints for the development of bio-based products are the availability of funds to 
invest in production capacity (with 74% of companies rating this as an important 
constraint), higher production costs compared to existing fossil based alternatives 
(72%), and increased or variable feedstock costs (70%), as shown in Figure 22. Where 
respondents were able to indicate an unlimited number of constraints, the availability of 
funds for necessary R&D, increased capital costs and technology maturity or risk 
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associated with new process development where identified as important constraints by 
more than two-thirds of respondents.  
 
Figure 22: Ranking the most important constraints for the development of bio-based products 
Source: EU bio-based industries survey. 
The issues of competitive production costs is rated as very high importance in both the 
drivers and constraints to the development of bio-based products, indicates that for 
successful or emerging products cost competitiveness is a key part of the value 
proposition, whilst for products still under development it is very important that the 
production costs become more competitive with the existing products in order for these 
products to achieve any market share.  
The Bio-TIC project (2014)15, 16 has done considerable work recently in identifying 
regulatory and non-technological hurdles that may inhibit innovation and prevent the 
realisation of the market and technological potential of industrial biotechnology in 
Europe. The key Bio-TIC sectors include bio-based chemical building blocks, plastics, and 
surfactants (alongside advanced biofuels and CO utilisation). The Bio-TIC non-
technological roadmap is based on an extensive literature study and the subsequent 
stakeholder discussion of its findings during eight regional workshops and more than 60 
expert interviews. Several barriers affecting the bio-based industries were highlighted, 
including: 
• Feedstock related barriers: the logistics of securing large quantities of biomass 
feedstocks all year round, and the availability of feedstock at affordable prices 
• Investment barriers and financial hurdles: the availability of project capital (specifically 
limited public funding for R&D and scale-up activities, and limited access to finance for 
SMEs, spin-offs and start-up companies), and the perception of high investment risk. 
• Poor public perception and awareness of industrial biotechnology and bio-based 
products. 
• Demand side policy barriers: an absence of incentives or efficient policies. There is no 
framework in Europe to promote bio-based products, and a wide variety of ecolabels 
and no standards for sustainable and bio-based products. 
• Other barriers: including barriers related to human resources (the availability of 
personnel with the right skills and curricula), collaboration efficiency (insufficient 
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knowledge exchange), intellectual property, and sustainability (no coherent policy 
framework for sustainability).  
More specifically, for chemical building blocks, the core issue appears to be the lack of 
general interest in production of bio-based chemical building blocks, whether it is 
expressed by low levels of investment, or a lack of demand side policy drivers or 
financial incentives for biochemicals. Demonstration scale-up activities are expensive, 
and in many cases not being carried out due to the lack of a clear economic case versus 
the fossil chemical counterfactual.  Whilst for polymers, the business case is mainly 
faced with problems related to price (vs. fossil substitutes), a lack of critical mass due to 
immature value chains, and no real regulatory support to foster their competitiveness. A 
lack of recycling systems for new polymers, poor public awareness and the need for clear 
standards/definitions are also hampering the sector. 
Similar themes regarding the barriers to the development of bio-based products are 
reported in other regions. In Canada, more than half of companies rated the lack of 
financial capital as a barrier to production and development of bio-based products as 
high, and 42% of companies rated the cost of biomass as a barrier to production and 
development as high.  
The cost and timeliness of regulatory approval was also rated as a high barrier by over 
half of companies in Canada, whilst few companies ranked barrier relating to product 
certification or approval as one of the three most important barriers (6.5%). However, 
industry wide perspectives, such as those presented by the Bio-TIC project, indicate a 
lack of demand side policies as a barrier.  
In the US, companies rated the following impediments to the commercialisation of bio-
based products as most significant: feedstock price, lack of capital (debt or equity), a 
high level of risk in relation to profit potential, and final product not cost competitive. 
These key factors are in very close agreement to those indicated by the EU bio-based 
industries survey. 
4.6. Impact of the EU bio-based industry on the EU economy 
The impact of the EU bio-based industry on the EU economy may be quantified by 
indicators such as the number of companies operating in the industry, the number of 
jobs, and sales revenues. This study focussed on those sections of the chemicals and 
materials industries that convert biomass feedstocks to primary products (or 
intermediates). The impacts may be defined as the direct jobs and revenues generated 
by these organisations, or the impacts may extend beyond the conversion of biomass 
feedstock to primary products (or intermediates) to include benefits to the upstream 
industries from additional markets for agricultural, forestry and waste materials, and the 
downstream industries, utilising the bio-based products in added value applications, for 
example the construction sector, textiles, automotive, among many others.  
Several studies have attempted to estimate the impact of the EU bio-based industry on 
the EU economy. Figures cited in the European Bioeconomy Strategy and Action Plan, 
(from The Knowledge Based Bio-Economy in Europe, 2010) estimate that the annual 
turnover relating to bio-based chemicals and plastics in the EU was €50 billion for 2009, 
and that such activities contributed 150,000 jobs to the EU economy1.  
More recent estimates based on EUROSTAT data for 201117 provides a comparable 
estimate for the manufacture of chemicals, chemical products, and plastics. Based on the 
assumption that the bio-based industry represents 5% of the European chemicals 
industry, they estimate that the turnover in the EU relating to the production of bio-
based chemicals, chemical products, and plastics was 76 billion EUR in 2011 and that the 
number of jobs in the manufacture of bio-based chemicals, chemical products and 
plastics was 60,000 in 2011. The number of additional jobs in the agricultural sector in 
the supply of feedstock is estimated at 30,000 – 60,000, bringing the total number of 
jobs to between 90,000 and 120,000.  
  
In order to contextualise the size of the bio-based industries, we may compare this to 
the EU chemicals industry. According to data and analysis produced by CEFIC, the EU 
chemicals industry is a long established industry, established over 150 year ago, which 
includes approximately 29,000 companies18. The EU chemicals industry generated a 
turnover of €527 billion in 2013. Over the last two decades EU chemical sales have 
almost doubled, however since 2011 there has been a slight decline in sales (2.7% 
between 2011 and 2012, and 1.6% between 2012 and 2013). Between 2010 and 2013, 
the ratio of sales within the EU vs Extra-EU exports has remained relatively stable with 
around three-quarters of sales within the EU. The number of employees employed 
directly by the EU chemical industry has remained unchanged since 2010 at 1.2 million 
people.  Regarding growth, absolute capital spending and the intensity of capital 
spending as a percentage of sales has remained flat between 2010 and 2013 (at an 
average of €18 billion per year), while spending on R&D has seen a small increase in 
absolute terms, but flat as a percentage of sales (at 1.6%).  
The bio-based industries have been compared to the paper and pulp industry and the 
biofuels industry in previous reports. According to the KBBE, the annual turnover for the 
biofuels industry in the EU was €6 billion for 2009, and the industry contributed 150,000 
jobs to the EU economy1. This indicates that whilst the two industries employ an equal 
number of people across the EU, the value added to the economy for each jobs within 
the chemical and materials sectors is eight times greater. Both the bio-based industries 
and the biofuels industries are dwarfed by the paper and pulp industry, which is 
estimated to contribute €375 billion to the economy in 2009, and contribute 1.8 million 
jobs.  
The EU bio-based industries survey collected data on the number of employees working 
on bio-based activities from 36 companies, out of a target population of 133 companies 
(27% response rate). The survey identified 2,334 employees directly employed in bio-
based activities. Also, 23 companies (17% response rate) provided data on the sales 
turnover in the EU of bio-based products, estimated at about €1.4 billion. These figures 
seem to indicate lower direct employment and turnover figures compared to the top-
down estimates from the studies mentioned above. However, the partial nature of the 
survey means it is difficult to provide an overall indication of the economic impacts and 
how they compare to the high-level top-down estimates.  Furthermore, there will be 
additional benefits realised in the production of value added consumer products. 
4.7. Comparison of the EU bio-based industry with key EU 
competitor countries   
Europe is seen as a global leader in various fields of biosciences and technologies, with a 
competitive edge in industrial biotechnology (IB) for enzyme, chemical, food and feed 
ingredients production. For example, 64% of all enzyme companies operate from within 
the EU19. Europe has good availability of biomass feedstocks, with advanced practices in 
the areas of agriculture, forestry and wastes. There are world leading bio-based 
technology companies operating in the EU, with a range of bio-based products already in 
the market, as demonstrated by the survey results, and an increasing portfolio of 
products anticipated to develop to 2020.  
However, according to EuropaBio a wide range of countries have introduced Bioeconomy 
policies (Figure 23), and nations such as the US, China, Canada, Japan, and India are 
rapidly adopting industrial biotechnology 2. The conditions for investment have been 
reported to be more attractive in the US and China (in particular for demonstration 
activities), with examples of EU technology being deployed there15, 16.  
The urgency of commercialising EU research has been recognised within the EU, and has 
led to the establishment of the Bio-based Industries Consortium (BIC), and the Bio-
Based Industries (BBI) Public-Private Partnership with the EU Horizon 2020 programme. 
These efforts and significant investment sums (€3.8billion) are looking to build new 
supply chains, scale-up research to flagship biorefineries, plus develop markets and 
  
policies for the products made15, 16. The impact of these programmes are not fully 
realised in the industry today.  
For the purposes of this study the US, China and Brazil are compared as competitor 
regions. These regions are reported to be leaders in the bio-based industry, based on 
existing production capacity, planned production capacity, industrial innovation, the 
status of complementary industries (for example biofuel production), and the availability 
of feedstock. Canada and Malaysia both have existing bio-based industries, but feature 
less prominently in reported commercialisation strategies of new developers, and are 
also discussed below. 
 
Figure 23: Countries which have dedicated or partial bioeconomy strategies  
Source: German Bioökonomierat (Bioeconomy Council) 
An outline of the current state of the bio-materials industry in each of these countries is 
given, focussing on the policy and financial support provided by the government, and 
assessing the available information on production capacity. However information on the 
production volumes and the value of the bio-based industries is not published for each 
country of interest, additionally the methodologies used to report on the size of the 
industry is different for each country, making direct comparisons between datasets 
challenging due to differences in the scope of products included. The limited availability 
of information for some key producing regions such as China, Brazil, and Malaysia 
represents a key data gap in the ability to quantitatively compare the EU bio-based 
industry to the rest of the world.    
Canada 
Canada has an abundance of natural resources, which presents opportunities for the 
development of the Bioeconomy. However despite initiatives at the province level in 
Alberta, British Columbia and Ontario there is no specific federal government strategy for 
  
the promotion or support of the bio-based sector, which may be impeding its 
development20. Financial support appears to be limited to biofuels, through the Next-
generation Biofuels Fund.  
Canada has published data on the bio-based industry. Statistics Canada published the 
Bioproducts Production and Development Survey in 2009, the third survey on bioproduct 
activity. Similar to the EU bio-based industry survey, the Bioproducts Production and 
Development Survey targeted all firms in Canada that use biomass feedstocks to 
develop or produce industrial bioproducts, and focussed on non-conventional products 
(excluding food, feed, medicines, wood composite products and traditional bioproducts). 
The scope includes the products included in the EU survey, and additionally biofuels and 
pesticides.   
The Survey reported that, in 2009, 208 firms were engaged in the production or 
development of bioproducts. Those companies reported total sales revenues of CAD14.9 
billion (2009) and sales revenues from bioproducts of CAD1.3 billion (2009). Spending 
on R&D activities for bioproducts or biomass totalled CAD74 million (2009). However, 
although these figures indicate an industry with good potential, they demonstrate a 
decline from 200321.  
USA 
In the USA the 2002 Farm Bill created the BioPreferred program in order to increase the 
purchase and use of bio-based products, and in February 2012 President Obama issued a 
Presidential Memorandum outlining steps to take greater advantage of the BioPreferred 
Program, aiming to significantly increase federal procurement of bio-based products. 
Furthermore in April 2012, the Obama administration launched the “National 
Bioeconomy Blueprint”. This is a national strategy laying out objectives to help achieve 
the full potential of the US Bioeconomy and highlighting achievements towards these 
objectives. This blueprint emphasised the importance of the Bioeconomy both as a 
growth industry for America and also for its value to society as a whole. The five 
strategic objectives which are identified focus on R&D, transition from lab to market, 
reforming regulations, training the workforce, and the development of collaborations and 
public-private partnerships.  
Specific policy support for the bio-based products industry in the US comes from the 
BioPreferred Program, which includes a voluntary labelling initiative for biobased 
products and a procurement requirement for federal agencies and their contractors to 
increase the purchase and use of biobased products. For financial support, the USDA 
Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance 
Program (formally called the Biorefinery Assistance Programme) gives loan guarantees 
of up to $250 million for the development of advanced biofuels, renewable chemicals and 
biobased product manufacturing. However the scope of this fund was only increased 
from advanced biofuels to include alternative chemical products in mid-2015. This 
revised fund has $200 million mandatory funding over three years, with discretionary 
funding of up to $375 million over five years22. In addition the Integrated Biorefineries 
programme provides funding to support crop establishment, although this is primarily 
focussed on the energy-use of biomass.  
One of the first large US surveys into the Bioeconomy was conducted in 2008 by the US 
International Trade Commission and was based largely on data collected directly from 
the industry via survey, relating to the years 2004 to 2007.  
A 2015 study for the USDA provides more up-to-date data, and suggests the US bio-
economy, and bio-based products sector in particular, has grown in the past seven 
years. Information was gathered from three main sources: interviews with government 
and industry experts, statistics from government agencies and published literature, and 
economic modelling using IMPLAN modelling software. The following overarching sectors 
are taken as contributing to the bio-based economy: agriculture and forestry, 
biorefining, bio-based chemicals, enzymes, bioplastic bottles and packaging, forest 
  
products and textiles. This report excluded energy, livestock, food, feed and 
pharmaceuticals products. 
The study indicates that the total contribution of the bio-based products industry to the 
US economy in 2013 was $369 billion, with 4 million people employed either directly or 
indirectly.  
The bio-based chemicals sector (defined as a chemical derived or synthesised in whole or 
in part from biological materials), which included plastics such as PHA and PLAs, 
biolubricants, biosolvents and dyes was estimated to contribute around $5 billion directly 
and $17.4 billion in total, considering multiplier effects, to the US economy in 2013, 
employing 22,950 people directly and 133,000 people when considering direct, indirect 
and induced employment. The entire chemicals sector was estimated to be 4% biobased.  
The EU bio-based economy survey results presented in this study indicate that value and 
direct employment figures for the US and EU bio-based chemicals sectors could be of the 
same order of magnitude.  
China 
In China’s 12th 5-year plan (laid out in 2011), biotechnology was one of their seven 
priority industries, although this was primarily focussed on drugs and medical 
technology23. The plan overall focussed on more sustainable development, rather than 
simply rapid growth, and considered the introduction of several environmental measures 
such as goals to limit GDP CO2 intensity, pollution limits, and new resource use and 
environmental taxes, which are likely to stimulate the bioeconomy24. 
Financial support for the development of bio-based chemicals and materials has been 
sourced from the Knowledge Innovation Program of the Chinese Academy of Sciences 
(from 1998 to 2010), and the National High Technology Research and Development 
Program of China (863 Programme) which began in 1986. 
No public government statistics or national data relating to the bio-based industry in 
China is available. Nevertheless, significant production capacity is being built at 
commercial scale, by both Chinese and International companies, who are attracted to 
China by low production and labour costs. Examples of such companies include Cardia 
Bioplastics, Hiusan Biosciences and Hexing Chemical25. Bioplastic materials produced in 
China include PBAT, PLA, PHA, PVA, PPC, and the combined existing production capacity 
has been estimated at about 85,000 tonnes per annum26. 
Brazil 
With a strong agricultural sector and well-established ethanol production industry, Brazil 
is well-placed to move into the emerging bio-materials sector. Brazil has a number of 
innovation policies in place and innovation is supported by the National Bank for Social 
Development (BNDES) and the Funding Authority for Studies and Projects (FINEP). In 
addition EMBRAPA (Brazilian Agricultural Research Corporation) has long supported the 
use of biotechnology in agriculture. Biotechnology was identified as a national strategic 
priority in 2003 and formally supported in the 2007 decree, Política de Desenvolvimento 
da Biotecnologia, which also established the National Biotechnology Committee27. 
The development of the biomaterials sector in Brazil is closely linked to the established 
bioethanol production from sugarcane industry. This is evidenced by the dual-purpose 
funding of the Joint Support Plan for Industrial Technological Innovation in Sugarcane-
based Ethanol and Chemical Sectors (PAISS) which focuses on innovation in both the 
agricultural and processing aspects of the sugarcane industry. Alongside the production 
of second-generation bioethanol and new gasification technologies, PAISS focuses on 
funding the development of new sugarcane products outside of the biofuels sector. 
PAISS has supported R$ 2.5 billion of projects to date.  
Although there is no country-wide survey or inventory of bio-based materials plants in 
Brazil, there are several large enterprises in this sector including the Braskem bio-based 
  
polyethylene plant, Cardia Bioplastics plant in São Paulo, the planned Moore Capital PHA 
production plant, and PHB Industrial S.A. 
Malaysia 
In 2005 Malaysia launched the National Biotechnology Policy (NBP) to develop 
agriculture, healthcare and industrial manufacturing, with the Malaysian Biotechnology 
Corporation (BiotechCorp) primarily responsible for its implementation. BiotechCorp has 
formed strategic partnerships with Italian, Belgian and German bio-based industry 
developers, with a view of Malaysia as a growing hub for the bioeconomy in South-East 
Asia28. 
In 2009 Malaysia introduced an accreditation scheme for qualified international and 
Malaysian biotechnology companies, called Bionexus. Bionexus companies benefit from 
support and significant funding such as 100% tax exemption for 10 years and double 
deductions on R&D expenditure29. In addition, Bionexus companies are able to access 
funding from the Biotechnology Commercialisation Fund. 
Focusing more specifically on bio-based feedstocks, the Bioeconomy Transformation 
Programme (BTP) was launched in 2012, providing a government platform to channel 
private sector investment into bio-based industries30, specifically targeting the 
production of biofuels, bioplastics and bio-based chemicals. By 2014 the BTP had 
identified and approved 25 bio-economy ‘trigger’ programmes which it was supporting.   
Finally, the National Biomass Strategy launched in 2013 recognises the importance of 
both bio-based chemicals and bio-fuels to leveraging the most value from Malaysia’s 
biomass resources.  
Despite such strong government support for the bio-economy in Malaysia, there is no 
overall inventory of bio-based products plants. Nevertheless, there are developments in 
this sector including the SIRIM Berhad PHA plant, the planned Johor bio-refining plant, 
and the Arkema and CJ Cheiljedang thiochemicals from sugars plant.  
Country Comparison 
The heat-map shown in Figure 24 compares the bio-based products sector in the 
five selected countries to that of the EU. Europe compares favourably to the other 
countries on all indicators, with some limitations in feedstock availability and 
current level of commercial activity. It should however be noted that it was not 
possible to fully quantitatively assess the current level of commercial activity due 
to a lack of data, and varied definitions of the ‘bio-economy’.  
  
 
Figure 24: Comparison of bio-economy across a number of countries, with focus on bio-based 
materials 
Source: Different sources.   
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5. Conclusions  
The census survey of the EU bio-based industries aimed to provide a description of the 
current status of the industry, to allow the JRC to monitor and analyse developments in 
the industry in Europe. The population is diverse in terms of company size, products, 
and markets supplied and therefore to provide a comprehensive description of the 
industry requires a full response. Feedback from the target population and other industry 
stakeholders has clearly indicated that there are major barriers to collecting the required 
data. The two main comments relate to concerns over the amount of time and resource 
required to collect such data and the availability of the data required (within the 
company), and also the commercial sensitivity of the data. This has clearly had an 
impact on the response rate and on the quality of some responses, particularly with 
open-ended questions to which respondents are required to input data or information 
which the respondent may have difficulty in researching or obtaining from within a large 
and diverse company structure. In addition, unless there is a clear value to the company 
from responding to the survey, or a legal obligation, companies will be hesitant to 
dedicate time and resources to responding. Developing statistical information, in 
particular in a novel, varied and competitive sector like the bio-economy will inevitably 
require a protracted effort and continuous engagement with the industrial community. 
Nevertheless, this survey obtained a response from almost half the target population, 
which though somewhat lower is not dissimilar to that of similar exercises carried out in 
North America. While the overall response rate was insufficient to provide a 
comprehensive picture of the sector, it does provide some important insights. In order to 
gain a more comprehensive insight into specific companies or sub-sectors of the bio-
based industry, follow-up (face-to-face) interviews with stakeholders could potentially be 
undertaken. Also, using the data gathered in this project and making analysis based on 
it publicly available could encourage other industry players to participate in future 
surveys. 
The response illustrates that there are a diverse set of active players ranging from large 
to micro companies, developing and producing a wide range of products from a wide 
range of feedstocks. The companies that responded to the survey report total bio-based 
product turnovers of the order of €6.8 billion globally and €1.4 billion in the EU. All 
respondents are positive about the outlook for growth in the industry. The response also 
indicates a rise in company activity since 2011, and there appear to be shifts in products 
being developed and produced, probably as a result of market testing, and technical 
development. The active European companies produce and sell globally, testimony of the 
global nature of the sector. 
Many of the companies are engaged in R&D activities in different parts of the world, 
meaning that there is probably competition to attract R&D investment to the EU, but also 
that there is potential for companies to capitalise on synergies from R&D being carried 
out and funded in different regions. Proximity to R&D appears to be a very important 
factor in determining early production location, alongside resource availability, existing 
infrastructure and proximity to market demand. Therefore, remaining competitive as a 
location for R&D is likely to have additional benefits in terms of promoting the 
manufacture of bio-based products in the EU.   
Improved profitability and improved product competitiveness, along with the 
development of innovative products, were cited as the three most important drivers for 
the development of bio-based products, indicating a relatively market driven sector. This 
indicates that there is a need to understand: the potential for cost reduction of certain 
routes and how to support this cost reduction; the availability and price of feedstock 
given competing uses; the R&D requirements and how to provide effective and targeted 
funding. Responses suggest a diversity of drivers associated with different value 
propositions (performance, competitiveness, environmental) and the potential to 
innovate. Factors such as policies relating to bio based products were given less 
prominence. Nevertheless, the sector could be enhanced by policy support, for example 
  
in the area of environmental performance of bio-based products relative to alternatives. 
These are key to providing positive future conditions for competitive bio-based products. 
Public funding is important to most respondents, with sources of funding ranging from 
pan-European to regional and local. 
  
  
References  
 
1. Clever Consult BVBA The Knowledge Based Bio-Economy (KBBE) in Europe: 
Achievements and Challenges – Full report. http://www.bio-
economy.net/reports/files/KBBE_2020_BE_presidency.pdf Meise, September 
2010.  (2010). 
2. EC Communication from the Commission to the European Parliament, the Council, 
the European Economic and Social Committee and the Committee of the Regions. 
Strategy for "Innovating for sustainable grow: a bioeconomy for Europe". 
http://ec.europa.eu/research/bioeconomy/pdf/official-strategy_en.pdf. European 
Commission (2012). 
3. EC Taking bio-based products from promise to market: Measures to promote the 
market introduction of innovative bio-based products. European Commission. 
Available at: http://bookshop.europa.eu/en/taking-bio-based-from-promise-to-
market-pbNB3109225/?CatalogCategoryID=lR4KABst5vQAAAEjxZAY4e5L.  
(2009). 
4. Dammer, L., Piotrowski, S. & Carus, M. Study on: Methodology framework for the 
bioeconomy observatory for the JRC. Nova-Institut. Project: Bioeconomy 
Information System and Observatory Project (BISO) – Set up of the Bioeconomy 
Observatory.  (2014). 
5. IIASA and Alterra Biomass Futures: Atlas of EU Biomass Potentials. Available at: 
http://ec.europa.eu/energy/intelligent/projects/sites/iee-
projects/files/projects/documents/biomass_futures_atlas_of_technical_and_econo
mic_biomass_potential_en.pdf  (2012). 
6. Carus, M. Bio-based Economy in the EU-27 - A first quantitative assessment of 
biomass use in the EU industry. Expert study for DG Research & Innovation 2012. 
http://www.bio-based.eu/policy/en/. nova-Institut, Hürth, Germany (2012). 
7. de Jong, E., Higson, A., Walsh, P. & Wellisch, M. Bio-based Chemicals. Value 
Added Products from Biorefineries - Task 42 Biorefinery. 
http://www.ieabioenergy.com/publications/bio-based-chemicals-value-added-
products-from-biorefineries/. IEA Bioenergy - Task 42 Biorefinery (2012). 
8. Harmsen, P. & Hackmann, M. Green building blocks for biobased plastics. 
http://www.groenegrondstoffen.nl/downloads/Boekjes/16GreenBuildingblocks.pdf
. Wageningen UR Food & Biobased Research (2013). 
9. US DOE Top Value Added Chemicals from Biomass. Volume I - Results of 
Screening for Potential Candidates from Sugars and Synthesis Gas. Energy 
Efficiency and Renewable Energy. U.S. Department of Energy (2004). 
10. Rothwell, N., Khamphoune, B. & Neumeyer, C. Results from Statistics Canada’s 
Bioproducts Production and Development Survey 2009. 
http://www.statcan.gc.ca/pub/88f0006x/88f0006x2011001-eng.htm. Statistics 
Canada. Business Special Surveys and Technology Statistics Division. Agriculture 
and Agri-food Canada (2011). 
11. USITC Industrial Biotechnology: Development and adoption by the US chemical 
and biofuel industries. Investigation N. 332-481. . United States International 
Trade Commission USITC Publication 4020 (2008). 
12. Ketels, C. The Role of Clusters in the Chemical Industry. Report, 2007. (Prepared 
for the Annual Conference of the European Petrochemical Association (EPCA)). 
http://www.hbs.edu/faculty/Pages/item.aspx?num=30557.  (2007). 
13. E4tech From the Sugar Platform to biofuels and biochemicals. Final report for the 
European Commission Directorate-General Energy. N° ENER/C2/423-
  
2012/SI2.673791. 
https://ec.europa.eu/energy/sites/ener/files/documents/EC%20Sugar%20Platfor
m%20final%20report.pdf. A consortium led by E4tech (UK) Ltd with Consorzio 
per la Ricerca e la Dimostrazione sulle Energie Rinnovabili (RE-CORD) and 
Stichting Dienst Landbouwkundig Onderzoek, Wageningen University and 
Research Centre (WUR) (2015). 
14. Dammer, L., Carus, M., Raschka, A. & Scholz, L. Market Developments of and 
Opportunities for biobased products and chemicals. http://bio-
based.eu/downloads/market-developments-opportunities-biobased-products-
chemicals/. Nova-Institut, Hürth, Germany (2013). 
15. Bio-TIC Overcoming hurdles for innovation in industrial biotechnology in Europe: 
Market Roadmap: Draft 3. http://www.industrialbiotech-europe.eu/new/wp-
content/uploads/2015/03/Market-Roadmap-V3-website.pdf.  (2015). 
16. Bio-TIC Overcoming hurdles for innovation in industrial biotechnology in Europe: 
Roadmap to overcome non-technological barriers: Draft 3. 
http://www.industrialbiotech-europe.eu/bio-tic/deliverables/.  (2015). 
17. Piotrowski, S., Carus, M. & Essel, R. Global bioeconomy in the conflict between 
biomass supply and demand. Nova-Institut, Hürth, Germany (2015). 
18. Benzing, T. & Mosquera, J. Measuring Bio-Based raw materials use in the 
chemical industry. https://biobs.jrc.ec.europa.eu/stakeholder/cefic-study-
measuring-bio-based-raw-materials-use-chemical-industry. CEFIC, European 
Chemical Industry Council, (2014). 
19. EC Bio-based Industries: Joint Technology Initiative. 
http://www.gppq.fct.pt/h2020/_docs/eventos/1459_ppt_barend_verachtert.pdf.  
(2013). 
20. Natural Resources Canada Towards an Integrated Action Plan for the Bioeconomy. 
Outcomes and Conclusions from a Critical Conversation at Carleton University. 
Report prepared for Natural Resources Canada. .  (2013). 
21. Sparling, D., Cheney, E. & Cranfield, J. Canada’s Shrinking Bioproduct Industry. 
Cairn Policy Brief, 29. Canadian Agricultural innovation and Regulation Network 
(2012). 
22. US Department of Agriculture Federal Register / Vol. 80, No. 121 / Wednesday, 
June 24, 2015 / Rules and Regulations.  (2015). 
23. KPMG China’s 12th Five-year Plan: Overview [online] Available from: 
http://www.kpmg.com/cn/en/issuesandinsights/articlespublications/publicationse
ries/5-years-plan/pages/default.aspx (Accessed 26th November 2011).  (2011). 
24. Fulton, M. 12th Five Year Plan - Chinese Leadership Towards a Low Carbon 
Economy. Deutsche Bank Group, DB Climate Change Advisors (2011). 
25. Babu, R.P., O’Connor, K. & Seeram, R. Current progress on bio-based polymers 
and their future trends. Progress in Biomaterials 2, 1-16 (2013). 
26. European Bioplastics Relevant regulations and supportive measures for the 
bioplastics industry in China [online] Available from: http://en.european-
bioplastics.org/blog/2014/09/17/relevant-regulations-and-supportive-measures-
for-the-bioplastics-industry-in-china/ (Accessed 25th November 2015)  (2014). 
27. Pugatch Building the Bioeconomy: Examining National Biotechnology Industry 
Development Strategies.  (2014). 
28. Eco-Business Malaysia on track to create bioeconomy hub in Asia-Pacific [online] 
Available from: http://www.eco-business.com/news/malaysia-on-track-to-create-
bioeconomy-hub-in-asia-pacific/ (Accessed 25th November 2015).  (2015). 
  
29. BiotechCorp Eligibility Criteria for BioNexus Status [online] Available from: 
http://www.biotechcorp.com.my/bionexus-development/bionexus-
status/opportunities/ (Accessed 26th November 2015).  (2015). 
30. EC-JRC International Bioeconomy Profile. Malaysia. European Commission Joint 
Research Centre (2014). 
 
  
Annex I: List of products in the scope   
 
Organic acids 
 
• Succinic acid  
• Adipic acid  
• Lactic acid  
• Itaconic acid  
• Acetic acid  
• Citric acid  
• Lauric acid  
• Sebacic acid  
• Formic acid  
• Levulinic acid  
• 2,5-Furandicarboxylic acid (FDCA)  
• Acrylic acid 
• 3-hydroxypropionic acid (3-HPA) 
• Glutamic acid 
• Terephthalic acid 
• Furfural 
• Methacrylic acid 
• Methyl methacrylate 
 
Alcohols 
• n-butanol 
• Isobutanol  
• 1,4-Butanediol (BDO)  
• 1,3-Propanediol (PDO)  
• Propylene glycol  
• Furfuryl alcohol  
 
Polymers  
• Derived from natural polymers 
o Cellulose ester, inc. cellulose acetates 
o Cellulose ether  
o Starch polymers, inc. composites  
• Derived from monomers 
o Polyhydroyalkanoates (PHAs), inc. PHB 
o Polyamides  
o Polyurethane (PUR) 
o Polylactic acid (PLA) 
o Polyethylene furanoate (PEF)  
o Polybutylene succinate (PBS)  
o Polycarbonates (PC)  
o Polymethyl methacrylate (PMMA)  
o Polybutadiene (PBD)  
o Polybutyrate (PBAT)  
o Polybutylene terephthalate (PBT) 
o Polyethylene (PE) 
o Polyvinyl chloride (PVC) 
o Polyvinyl acetate (PVA) 
o Polystyrene (PS) 
o Polypropylene (PP) 
  
o Polyethylene glycol (PEG) 
o Polyethylene terephthalate (PET) 
 
Composite materials 
• Wood-plastic composites (WPC)  
• Cork reinforced plastics  
• Other natural fibre reinforced plastics 
 
Others  
• Hydroxymethyl-furfural (HMF) 
• Epichlorohydrin  
• Isoprene  
• Isosorbide 
• Farnesene 
• Fatty amines 
• Ethylene 
• Acetone 
• Ethylene glycol 
• Para-xylene 
 
Other bio-based products used in the following applications: 
• Surfactants 
o Fatty alcohol ethoxylates/ethers  
o Fatty alcohol ether sulfates  
o Fatty alcohol sulfates  
o Ester quats  
o Alkyl polyglucosides 
o Lipopeptides and digopeptites 
o Glycolipids, inc. sophorolipids 
o Polymeric surfactants 
• Solvents 
• Binders  
• Plasticisers 
o Phthalate esters  
• Paints/coatings 
o Paint additives  
o Printing colours 
• Lubricants 
o Mould release agents  
o Chain & bearing lubricants  
o Hydraulic fluids 
  
  
Annex II: On-line questionnaire 
1. Introduction 
This survey aims to collect data on the current status and expected evolution of the bio-
based industry within the EU. Results of the survey will input to the JRC Bio-economy 
Information System Observatory.   
 
This survey is part of a wider Study of the EU Bio-based Industry; commissioned by 
the European Commission’s Joint Research Centre and carried out by E4tech and Agra 
CEAS Consulting.  The study aims to provide a comprehensive analysis of business 
activity to assist the JRC in monitoring and analysing developments in the bio-based 
industry in Europe, specifically addressing gaps in the existing data resources.  
 
The study will establish, for the first time, transparent market data which will improve 
the sector’s visibility and support investment decisions and policy actions. 
2. Instructions 
The online survey may be accessed here https://www.surveymonkey.com/r/NR3QWNK  
 
We strongly recommend that you review the questions in advance to gather any 
information required prior to submitting your response online.  This pdf copy of the 
questionnaire is provided for this purpose.  
 
It is not possible to save your online response to resume at a later date and therefore 
the online survey should be completed in one session.  
 
Should you experience any technical difficulties in completing and submitting the online 
survey, please do not hesitate to contact Clifford.Biggs@ceasc.com.   
3. Key definitions 
For the purpose of this survey ‘bio-based’ products relate to products derived in whole or 
in part of biological products from biomass (including plant, animal, and marine or 
forestry materials).   
 
The focus of the survey is on addressing gaps in the existing data resources, and 
therefore includes the material use of biomass, excluding food, feed and bio-energy. 
Other existing bio-based industries are also considered out of scope of this study 
because data relating to these existing industries is reported elsewhere. This includes 
pulp and paper, textiles, leather, fur, wood and wicker products, and pharmaceuticals.  
 
A brief description of the bio-based products included in the scope of the survey is 
outlined below.   
  
4. Product Scope 
The survey aims to collect data on the current status and expected evolution of the bio-
based industry within the EU. 
 
This survey is part of a wider Study of the EU Bio-based Industry, which will assist 
the JRC in monitoring and analysing developments in the bio-based industry in Europe, 
specifically addressing gaps in the existing data resources.  
 
The production of food, feed and bio-energy are outside the scope of the study, as data 
relating to the production and value of these sectors is reported under existing 
frameworks. The study focuses on the material use of biomass, including chemicals, 
polymers, and fibres. 
 
Some material products are defined as outside of the scope of this study because data 
relating to these existing industries is reported elsewhere. This includes pulp and paper, 
textiles, leather, fur, wood and wicker products, and pharmaceuticals. The JRC is 
concerned about the impacts on existing industries, and the study will report on potential 
impacts. 
5. Survey scope 
The following simplified value chain diagram is provided to give an indication of the 
products included in the scope of the survey. For the avoidance of doubt, a more 
detailed list of products is included in the initial screening questions.  
 
Chemical substances most commonly used as biofuels are considered outside of the 
scope of this survey (e.g. ethanol, FAME and HVO). Whilst these products may be used 
directly in non-fuel applications or may be used as an intermediate in the production of 
bio-based materials, data relating to production capacity, production volumes, revenue 
and investment, is already reported elsewhere.  
 
However, where these substances are intermediates for the production of other chemical 
and material products, the derived products are within the scope of this survey; for 
example the conversion of ethanol to ethylene. In this case, ethanol will be considered a 
feedstock for the production of ethylene.  
 
The production of biofuels also leads to co-products, for example glycerol from the 
production of FAME, and carbon dioxide from the production of ethanol. These co-
products may be utilised in the production of chemical and material products. As the 
production of biofuel is outside of the scope of the survey, the production of biofuel co-
products is also outside of the scope of the survey. Chemicals and materials derived 
from biofuel co-products are however within the scope of the survey. In this case, the 
biofuel co-product will be considered a feedstock for the bio-based industry, to avoid 
duplicating and potentially double counting the impacts of biofuel manufacturing 
capacity.  
 
If you have any further questions regarding the scope of the survey please do not 
hesitate to contact Lucy.Nattrass@E4tech.com.  
  
 
 
  
6. Contact Information 
*Q1. Please provide contact details for your company and for the person 
responsible for completing this questionnaire. 
 Company name  
 Address  
 Country  
 Company telephone number (incl. country code)  
 Company email address  
 Company website  
 Person to be contacted regarding this questionnaire  
 Job role or title (e.g. Director)  
 Contact telephone number and extension (incl. country code)  
 Contact email address 
 
ANSWER: insert information 
 
 
 
Continue survey; go to Screening 
7. Screening 
*Q2. Does your company do ANY of the following: 
 
(1) generate sales turnover OR employ people in the EU at present? 
 
OR 
 
(2) expect to generate sales turnover OR employ people in the EU by 2020? 
 
 
ANSWER: YES – continue survey; go to Screening (2) 
ANSWER: NO – Exit survey. 
  
  
8. Screening (2) 
*Q3. Does your company currently produce, or expect to produce by 2020, ANY 
of the following bio-based products? 
 
 Organic Acids 
 
 Alcohols (excluding ethanol) 
 
 Polymers derived from natural polymers, or monomers 
 
 Composite Materials 
 
 Others from the following list: 
o Hydroxymethyl-furfural (HMF) 
o Epichlorohydrin  
o Isoprene  
o Isosorbide 
o Farnesene 
o Fatty amines 
o Ethylene 
o Acetone 
o Ethylene glycol  
o Para-xylene 
 
 Others for use in the following applications: 
o Surfactants 
o Solvents 
o Binders 
o Plasticisers 
o Paintings/coatings 
o Lubricants 
 
 
ANSWER: YES – continue survey; go to Organic acids 
ANSWER: NO – Exit survey. 
 
  
  
9. Organic acids 
*Q4. Does your company currently produce bio-based organic acids, or expect 
to produce any by 2020? 
 
 
ANSWER: YES – continue survey; go to Organic acids (2) 
ANSWER: NO – continue survey; go to Alcohols 
10. Organic acids (2) 
*Q5. Please select all the bio-based organic acids which your company 
currently produces, and those which it expects to produce by 2020.   
 
If the product is both currently produced and expected to be produced in 2020, please 
select both columns. 
 
ANSWER: Tick all that apply  
 
 Currently produced Expect to produce by 2020 
Succinic acid  
Adipic acid  
Lactic acid  
Itaconic acid  
Acetic acid  
Citric acid  
Lauric acid  
Sebacic acid  
Formic acid  
Levulinic acid  
2,5-Furandicarboxylic acid (FDCA) 
Acrylic acid 
3-hydroxypropionic acid (3-HPA) 
Glutamic acid 
Terephthalic acid 
Furfural 
Methacrylic acid  
Methyl methacrylate 
Other (please specify) 
  
 
For other, please specify:  
 
If a product or products is not included in this list, please contact 
Lucy.Nattrass@e4tech.com  
 
 
 
Continue survey; go to Alcohols  
  
11. Alcohols 
*Q6. Does your company currently produce bio-based alcohols, or expect to 
produce any by 2020? 
 
 
ANSWER: YES – continue survey; go to Alcohols (2) 
ANSWER: NO – continue survey; go to Polymers 
12. Alcohols (2) 
*Q7. Please select all the bio-based alcohols which your company currently 
produces, and those which it expects to produce by 2020.   
 
If the product is both currently produced and expected to be produced in 2020, please 
select both columns. 
 
ANSWER: Tick all that apply  
 
 Currently produced Expect to produce by 2020 
n-butanol 
Isobutanol  
1,4-Butanediol (BDO)  
1,3-Propanediol (PDO)  
Propylene glycol  
Furfuryl alcohol 
Other (please specify) 
  
 
For other, please specify:  
 
If a product or products is not included in this list, please contact 
Lucy.Nattrass@e4tech.com  
 
 
 
Continue survey; go to Polymers 
13. Polymers 
*Q8. Does your company currently produce bio-based polymers, or expect to 
produce any by 2020? 
 
 
ANSWER: YES – continue survey; go to Polymers (2) 
ANSWER: NO – continue survey; go to Composite materials 
  
  
14. Polymers (2) 
*Q9-10. Please select all the bio-based polymers which your company currently 
produces, and those which it expects to produce by 2020.   
 
If the product is both currently produced and expected to be produced in 2020, please 
select both columns. 
 
ANSWER: Tick all that apply  
 
 Currently produced Expect to produce by 2020 
Q9. Derived from natural 
polymers 
Cellulose ester, inc. cellulose 
acetates 
Cellulose ether  
Starch polymers, inc. composites 
Other (please specify) 
 
Q10. Derived from monomers 
Polyhydroyalkanoates (PHAs), inc. 
PHB 
Polyamides  
Polyurethane (PUR) 
Polylactic acid (PLA) 
Polyethylene furanoate (PEF)  
Polybutylene succinate (PBS)  
Polycarbonates (PC)  
Polymethyl methacrylate (PMMA)  
Polybutadiene (PBD)  
Polybutyrate (PBAT)  
Polybutylene terephthalate (PBT)  
Polyethylene (PE) 
Polyvinyl chloride (PVC) 
Polyvinyl acetate (PVA) 
Polystyrene (PS) 
Polypropylene (PP)  
Polyethylene glycol (PEG)  
Polyethylene terephthalate (PET) 
Other (please specify) 
  
 
For other, please specify:  
 
If a product or products is not included in this list, please contact 
Lucy.Nattrass@e4tech.com  
 
 
 
Continue survey; go to Composite materials  
  
15. Composite materials 
*Q11. Does your company currently produce bio-based composite materials, or 
expect to produce any by 2020? 
 
 
ANSWER: YES – continue survey; go to Composite materials (2) 
ANSWER: NO – continue survey; go to Other bio-based products 
16. Composite materials (2) 
*Q12. Please select all the bio-based composite materials which your company 
currently produces, and those which it expects to produce by 2020.   
 
If the product is both currently produced and expected to be produced in 2020, please 
select both columns. 
 
ANSWER: Tick all that apply  
 
 Currently produced Expect to produce by 2020 
Wood-plastic composites (WPC)  
Cork reinforced plastics  
Other natural fibre reinforced 
plastics 
Other (please specify) 
  
 
For other, please specify:  
 
If a product or products is not included in this list, please contact 
Lucy.Nattrass@e4tech.com  
 
 
 
Continue survey; go to Other bio-based products 
17. Other bio-based products 
*Q13. Does your company currently produce any other bio-based products, or 
expect to produce any by 2020? 
 
 
ANSWER: YES – continue survey; go to Other bio-based products (2) 
ANSWER: NO – continue survey; go to Company information 
  
  
18. Other bio-based products (2) 
Q14-20. Please select all the other bio-based products which your company 
currently produces, and those which it expects to produce by 2020.   
 
If the product is both currently produced and expected to be produced in 2020, please 
select both columns. 
 
ANSWER: Tick all that apply  
 
 Currently produced Expect to produce by 2020 
Q14. Surfactants 
Fatty alcohol ethoxylates/ethers  
Fatty alcohol ether sulfates  
Fatty alcohol sulfates  
Ester quats  
Alkyl polyglucosides 
Lipopeptides and digopeptites 
Glycolipids, inc. sophorolipids 
Polymeric surfactants 
Other (please specify) 
  
Q15. Solvents 
Other (please specify) 
  
Q16. Binders  
Other (please specify) 
  
Q17. Plasticisers 
Phthalate esters 
Other (please specify) 
  
Q18. Paints/coatings 
Paint additives  
Printing colours 
Other (please specify) 
  
Q19. Lubricants 
Mould release agents  
Chain & bearing lubricants  
Hydraulic fluids 
Other (please specify) 
  
Q20. Others 
Hydroxymethyl-furfural (HMF) 
Epichlorohydrin  
Isoprene  
Isosorbide 
Farnesene 
Fatty amines 
Ethylene 
Acetone 
Ethylene glycol  
Para-xylene 
Other (please specify) 
  
 
For other, please specify:  
 
If a product or products is not included in this list, please contact 
Lucy.Nattrass@e4tech.com  
 
 
  
 
Continue survey; go to Company information 
19. Company information 
Q21. What is the ownership structure of your company?  
 Public limited liability company 
 Private limited liability company 
 Other 
 If other, please specify 
 
ANSWER: tick the most appropriate definition 
 
 
 
Q22. Is your company a subsidiary of a larger company? 
 YES 
 NO 
 If YES, please specify the parent company name. 
 
ANSWER: tick the most appropriate definition 
 
 
 
Q23. Is your company a joint venture? 
 YES 
 NO 
 If YES, please specify joint venture company name(s). 
 
ANSWER: tick the most appropriate definition 
 
 
 
Continue survey; go to Production facilities in EU Member States  
  
20. Production facilities in EU Member States 
*Q24. Does your company have bio-based production facilities in the EU? 
 
 
ANSWER: YES – continue survey; go to Production facilities in EU Member States 
(2) 
ANSWER: NO – continue survey; go to Production facilities outside the EU. 
21. Production facilities in EU Member States (2) 
Q25-26: Please provide details of your company's bio-based production 
facilities in the EU; 
 Status 
 Location (Member State) 
 Location (Region / town) 
 
Please use one row per facility. When you have included all EU facilities, you can leave 
remaining rows blank.  
 
ANSWER: Insert information 
 
 Q25(a). Status Q25(b). Country Q26. Region/town 
1 e.g. Pilot e.g. Austria  
2 e.g. Demonstration e.g. Belgium  
3 e.g. Commercial (active) e.g. Bulgaria  
4 e.g. Commercial (dormant) e.g. Croatia  
5    
6    
7    
8    
9    
10    
 
If your company has more than 10 production facilities in the EU, please contact 
clifford.biggs@ceasc.com  
 
 
 
  
Continue survey; go to Production facilities in EU Member States (3) 
22. Production facilities in EU Member States (3) 
Q27. What were the key reasons for selecting the location of the facilities listed 
above? 
 
ANSWER: tick all that apply 
 
Factors 
Tick if 
applicable 
Policy and regulation (e.g. policies to promote the use of bio-based products or 
industrial development, environmental regulations, etc.) 
 
Financial support (e.g. availability of production subsidies, market incentives and/or 
capital grants, etc.) 
 
Project financing (e.g. availability and/or terms of project finance)  
Proximity to customer demand (e.g. business customer and/or final consumer)  
Feedstock availability  
Feedstock cost  
Other operational costs (e.g. energy, other consumables, wages, etc.)  
Proximity to R&D activities  
Proximity to existing commercial activity  
Proximity to skilled labour force  
Ease of siting (e.g. brownfield/greenfield site, planning requirements)  
Infrastructure (e.g. waste treatment infrastructure)  
Other (please specify)  
 
For other, please specify:  
 
 
 
Continue survey; go to Production facilities outside the EU  
  
23. Production facilities outside the EU 
*Q28. Does your company have bio-based production facilities outside the EU? 
 
 
ANSWER: YES – continue survey; go to Production facilities outside the EU (2) 
ANSWER: NO – continue survey; go to Industry associations 
24. Production facilities outside the EU (2) 
Q29-30: Please provide details of your company's bio-based production 
facilities outside the EU; 
 Status 
 Location (Continent) 
 Location (Country) 
 
Please use one row per facility. When you have included all non-EU facilities, you can 
leave remaining rows blank.  
 
ANSWER: Insert information 
 
 Q29(a). Status Q29(b). Continent Q30. Country  
1 e.g. Pilot e.g. Other Europe (non-EU)  
2 e.g. Demonstration e.g. North America  
3 e.g. Commercial (active) e.g. South & Central America  
4 e.g. Commercial (dormant) e.g. Asia  
5  e.g. Oceania  
6  e.g. Africa  
7    
8    
9    
10    
 
If your company has more than 10 production facilities outside the EU, please contact 
clifford.biggs@ceasc.com  
 
 
 
Continue survey; go to Production facilities outside the EU (3) 
  
25. Production facilities outside the EU (3) 
Q31. What were the key reasons for selecting the location of the facilities listed 
above? 
 
ANSWER: tick all that apply 
 
Factors 
Tick if 
applicable 
Policy and regulation (e.g. policies to promote the use of bio-based products or 
industrial development, environmental regulations, etc.) 
 
Financial support (e.g. availability of production subsidies, market incentives and/or 
capital grants, etc.) 
 
Project financing (e.g. availability and/or terms of project finance)  
Proximity to customer demand (e.g. business customer and/or final consumer)  
Feedstock availability  
Feedstock cost  
Other operational costs (e.g. energy, other consumables, wages, etc.)  
Proximity to R&D activities  
Proximity to existing commercial activity  
Proximity to skilled labour force  
Ease of siting (e.g. brownfield/greenfield site, planning requirements)  
Infrastructure (e.g. waste treatment infrastructure)  
Other (please specify)  
 
For other, please specify:  
 
 
 
Continue survey; go to Industry associations  
  
26. Industry associations 
*Q32. Is your company a member of any chemical or bio-based industry 
association? 
 
 
ANSWER: YES – continue survey; go to Industry associations (2) 
ANSWER: NO – continue survey; go to Research and development 
27. Industry associations (2) 
Q33-34: Is your company a member of any chemical or bio-based industry 
associations?  
 
ANSWER: tick all that apply 
 
Q33. EU Level Association 
 AEBiom  European Biomass Association 
 APAG  European Oleochemicals and Allied Products Group Plastics Europe 
 BIC   Bio-based Industries Consortium 
 CEFIC  European Chemical Industry Council 
 CIRFS  European Man-Made Fibres Association 
 EB   European Bioplastics 
 EERA  European Energy Research Alliance 
 EFB   European Federation of Biotechnology 
 EFCC  Federation for Construction Chemicals 
 ERRMA  European Renewable Resources and Materials Association 
 EuropaBio  European Association for Bio-industries 
 PE   Plastics Europe 
 Other (please specify) 
 
For other, please 
specify: 
 
 
 
Q34. Member State level (Member State mentioned first) 
 AT  FCIO  Fachverband der Chemischen Industrie Österreichs 
 BE  Essenscia Belgian Federation for Chemistry and Life Sciences Industries 
 BE  VALBIOM Valorisation de la Biomasse asbl. 
 BG  BKTDCP Branshova Kamara Turgovskite Drujestva Chimicheskata Promishlenost 
 HR  UKI  Udruzenje Kemijske Industrije 
 CZ  SCHP  Association of Chemical Industry of the Czech Republic 
 DK  PI  Procesindustrien 
 EE  EKL  Eesti Keemiatoostuse Liit 
  
 FI  KT RY  Kemianteollisuus ry 
 FR  ACDV  Association Chimie du Végétal 
 FR  ADEME Agence de l'Environnement et de la Maîtrise de l'Energie 
 FR  UIC  Union des Industries Chimiques 
 DE  DIB  Deutsche Industrievereinigung Biotechnologie 
 DE  FNR  Fachagentur Nachwachsende Rohstoffe e.V. 
 DE  VCI  Verband der Chemischen Industrie e.V. 
 EL  HACI  Hellenic Association of Chemical Industries 
 HU  MAVESZ Hungarian Chemical Industry Association 
 IE  IPCMF  PharmaChemical Ireland 
 IT  FEDERCHIMICA Federazione Nazionale dell'Industria Chimica 
 IT  INNOVHUB Stazioni Sperimentali per l'industria 
 LV  LKUFUA Latvijas Kimijas Un Farmacijas Uznemeju Asociacija 
 LT  LCPIA  Lietuvos Chemijos Pramones Imoniu Asociacija 
 NL  VNCI  Vereniging van de Nederlandse Chemische Industrie 
 PL  PIPC  Polish Chamber of Chemical Industry 
 PT  APEQ  Associação Portuguesa das Empresas Químicas 
 RO  APDCR Romanian Chemicals Producers and Distributors Association 
 SK  ZCHFP Zväz chemického a farmaceutického priemyslu Slovenskej republiky 
 SI  GZS  Chamber of Commerce and Industry of Slovenia Dimiceva 
 ES  FEIQUE Federacion Empresarial de la Industria Quimica Espanola 
 SE  IKEM  Innovation and Chemical Industries in Sweden 
 UK  CIA  Chemical Industries Association 
 Other (please specify) 
 
For other, please 
specify: 
 
 
 
 
Continue survey; go to Research and development  
  
28. Research and development 
*Q35. Does your company carry out R&D activities for bio-based products in 
the EU? 
 
ANSWER: YES 
ANSWER: NO 
 
 
 
Continue survey; go to Research and development (2) 
29. Research and development (2) 
*Q36. Does your company carry out R&D activities for bio-based products 
outside the EU? 
 
 
ANSWER: YES – continue survey; go to Research and development (3) 
ANSWER: NO – continue survey; go to Drivers for development 
30. Research and development (3) 
Q37. In which regions outside the EU does your company have R&D activities 
for bio-based products?  
 Other Europe (non-EU) 
 North America 
 South & Central America 
 Asia 
 Oceania 
 Africa 
 
ANSWER: tick all that apply. 
 
 
 
Continue survey; go to Drivers for development  
  
31. Drivers for development 
Q38. From the list, please indicate the importance of the following DRIVERS for 
the development of bio-based products by your company. 
 
ANSWER: tick the relative importance of each driver 
 
 
 
not 
important 
at all 
not very 
important 
neutral important 
very 
important 
1 Improved profitability      
2 Improved product competitiveness      
3 Improved environmental performance      
4 Improved product properties or 
performance 
     
5 Potential for the development of 
innovative products with improved 
properties or performance 
     
6 Product diversification      
7 Market demand increase      
8 Sales growth potential      
9 Potential to increase market share      
10 Contribution toward company 
sustainability goals 
     
11 Production related to current 
competencies 
     
12 Availability of public funding      
13 Policies relating to bio-based products      
14 Other (please specify)      
 
For other, please specify:  
 
 
 
Continue survey; go to Drivers for development (2)  
  
32. Drivers for development (2) 
Q39. From the list, please indicate the 3 (THREE) MOST IMPORTANT DRIVERS 
for development of bio-based products by your company 
 Improved profitability 
 Improved product competitiveness 
 Improved environmental performance 
 Improved product properties or performance 
 Potential for the development of innovative products with improved properties or 
performance 
 Product diversification 
 Market demand increase 
 Sales growth potential 
 Potential to increase market share 
 Contribution toward company sustainability goals 
 Production related to current competencies 
 Availability of public funding 
 Policies relating to bio-based products 
 Other (please specify) 
 
ANSWER: tick the three (3) most important 
 
For other, please specify:  
 
 
 
Continue survey; go to Constraints on development  
  
33. Constraints on development 
Q40. From the list, please indicate the importance of the following 
CONSTRAINTS on the development of bio-based products by your company 
 
ANSWER: tick the relative importance of each driver 
 
 
 
not 
important 
at all 
not very 
important 
neutral important 
very 
important 
1 Higher production costs compared to 
existing fossil based alternatives 
     
2 Increased capital costs      
3 Increased or variable feedstock costs      
4 Increase energy demand and/or cost      
5 Other operational costs      
6 Availability of funds to invest in 
production capacity 
     
7 Availability of funds for necessary R&D      
8 Technology maturity or risk associated 
with new process development 
     
9 Existing patents of competitors, or other 
restrictions relating to existing IP 
     
10 Product properties or performance      
11 Barriers to achieving product 
certification 
     
12 Other (please specify)      
 
For other, please specify:  
 
 
 
Continue survey; go to Constraints on development (2)  
  
34. Constraints on development (2) 
Q41. From the list, please indicate the 3 (THREE) MOST IMPORTANT 
CONSTRAINTS on the development of bio-based products by your company 
 Higher production costs compared to existing fossil based alternatives 
 Increased capital costs 
 Increased or variable feedstock costs 
 Increase energy demand and/or cost 
 Other operational costs 
 Availability of funds to invest in production capacity 
 Availability of funds for necessary R&D 
 Technology maturity or risk associated with new process development 
 Existing patents of competitors, or other restrictions relating to existing IP 
 Product properties or performance 
 Barriers to achieving product certification 
 Other (please specify) 
 
ANSWER: tick the three (3) most important 
 
For other, please specify:  
 
 
 
Continue survey; go to EU employees  
  
35. EU employees 
Q42. What was the total number of employees in your company in the EU? 
 
ANSWER: insert information 
 
Year Insert number of employees 
2010  
2011  
2012  
2013  
 
 
 
Q43. What share (%) was employed in bio-based activities in the EU? 
 
ANSWER: insert information 
 
Year Insert % employed in bio-based activities 
2010  
2011  
2012  
2013  
 
 
 
Q44. What share (%) was involved in R&D activities related to bio-based 
products in the EU? 
 
ANSWER: insert information 
 
Year Insert % employed in bio-based R&D 
2010  
2011  
2012  
  
2013  
 
 
 
Continue survey; go to Production 
36. Production 
Q45. What types of processes does your company use for the production of bio-
based products in the EU? 
 
ANSWER: tick all that apply 
 
Fermentation Enzymatic Catalytic Other (please specify) 
    
 
For other, please specify:  
 
 
Q46. What was your company’s total annual output (in tonnes) of bio-based 
products in the EU?  
 
ANSWER: insert information 
 
Year Insert quantity in tonnes 
2010  
2011  
2012  
2013  
 
 
Q47. What share (%) of EU bio-based product output was sold in the EU? 
 
Year Insert % 
2010  
2011  
  
2012  
2013  
 
 
Q48. How is the share (%) of bio-based product output sold in the EU expected 
to change by 2020? 
 
ANSWER: tick the most applicable  
 
increase >100% increase <100% No change Decrease  Decrease to zero 
     
 
 
Continue survey; go to Feedstock 
37. Feedstock 
Q49-55: What type(s) of feedstock does your company use to produce bio-
based products in the EU? 
 
ANSWER: tick all that apply 
 
Feedstock 2010 2011 2012 2013 
Q49. Fibres     
Chemical pulp 
Cork 
Cotton fibre 
Flax / Hemp 
Jute / Kenaf 
Wood 
Other fibre (please specify) 
    
Q50. Sugars     
Sugar beet 
Sugar cane 
Other sugar (please specify) 
    
Q51. Starch     
Cassava 
Maize / Corn 
Potato 
    
  
Wheat 
Other starch (please specify) 
Q52. Vegetable oils     
Coconut oil 
Linseed oil 
Palm oil 
Rapeseed oil 
Soybean oil 
Other vegetable oil (please specify) 
    
Q53. Residues     
Agricultural residues 
Animal fat 
Animal proteins 
Other residues (please specify) 
    
Q54. Alcohols     
Bio-ethanol 
Bio-methanol 
Glycerol 
Other alcohols (please specify) 
    
Q55. Other (please specify)     
Other (please specify)     
 
For other, please specify:  
 
 
 
Continue survey; go to Feedstock (2)  
  
38. Feedstock (2) 
Q56. What share (%) of bio-based feedstock is sourced from within the EU (i.e. 
feedstock of EU origin)? 
 
ANSWER: insert information 
 
Year Insert % sourced from the EU 
2010  
2011  
2012  
2013  
 
 
 
Q57. What is the share (%) of bio-based feedstock in total feedstock use for 
producing bio-based products in the EU?  
 
ANSWER: insert information 
 
Year Insert % bio-based feedstock in total 
2010  
2011  
2012  
2013  
 
 
 
Q58. How is the contribution of bio-based feedstock to total feedstock use 
likely to change by 2020? 
 
ANSWER: tick the most applicable  
 
increase >100% increase <100% No change Decrease  Decrease to zero 
     
 
  
 
 
Continue survey; go to Sales turnover 
39. Sales turnover 
Q59. What was your company’s total sales turnover of bio-based products 
worldwide?  
 
ANSWER: insert information 
 
Year Insert turnover in Euros 
2010  
2011  
2012  
2013  
 
 
 
Q60. How is total sales turnover of bio-based products worldwide expected to 
change by 2020? 
 
ANSWER: tick the most applicable  
 
increase >100% increase <100% No change Decrease  Decrease to zero 
     
 
 
 
Continue survey; go to Sales turnover (2)  
  
40. Sales turnover (2) 
Q61: What was your company’s total sales turnover in the EU (i.e. fossil-based 
and bio-based products)? 
 
ANSWER: insert information 
 
Year Insert turnover in Euros 
2010  
2011  
2012  
2013  
 
 
 
Q62. What was your company’s total sales turnover of bio-based products in 
the EU? 
 
ANSWER: insert information 
 
Year Insert turnover in Euros 
2010  
2011  
2012  
2013  
 
 
 
Q63. How is total sales turnover of bio-based products in the EU expected to 
change by 2020? 
 
ANSWER: tick the most applicable  
 
increase >100% increase <100% No change Decrease  Decrease to zero 
     
 
  
 
 
Continue survey; go to Costs 
41. Costs 
Q64-67. What was the approximate contribution (%) of each of the following 
categories to production costs for bio-based products produced in the EU? 
 
ANSWER: insert information 
 
Q64. 2010  Q65. 2011  Q66. 2012  Q67. 2013 
Feedstock   Feedstock   Feedstock   Feedstock  
Labour   Labour   Labour   Labour  
Utilities   Utilities   Utilities   Utilities  
Other 
OPEX 
  Other 
OPEX 
  Other 
OPEX 
  Other 
OPEX 
 
R&D   R&D   R&D   R&D  
CAPEX   CAPEX   CAPEX   CAPEX  
Total 100%  Total 100%  Total 100%  Total 100% 
 
 
Continue survey; go to Public funding 
42. Public funding 
*Q68. Has your company received public funding since 2010?   
 
 
ANSWER: YES – continue survey; go to Public funding (2) 
ANSWER: NO – Exit survey. 
  
  
43. Public funding (2) 
Q69. What was the total value (in Euros) of public funding received? 
 
ANSWER: insert information 
 
Year Insert funding value in Euros 
2010  
2011  
2012  
2013  
 
 
 
Q70. What was the name(s) of the programme from which public funding was 
received? 
 
ANSWER: insert information 
 
Year Insert name of funding programme 
2010  
2011  
2012  
2013  
 
 
 
Q71. Was the public funding programme from which funds were received part 
of an ‘EU Framework Programe’?  
 
ANSWER: insert information 
 
Year Select option 
2010 YES / NO / Don’t know 
2011 YES / NO / Don’t know 
  
2012 YES / NO / Don’t know 
2013 YES / NO / Don’t know 
 
 
End of survey 
  
  
Annex III: Detailed answers  
This section presents an analysis of the data submitted in response to the survey 
questions.  
1. Bio-based products 
Q4, Q6, Q8, Q11 and Q13.  Does your company currently produce bio-based organic 
acids (Q4.), alcohols (Q6.), polymers (Q8.), composite materials (Q11.) or other (Q13.), 
or expect to produce any by 2020?   
Figure A25 shows the number of companies which either currently produce and/or 
expect to produce bio-based products by 2020.  The results are summarised as follows:  
 (Q4.) 26 companies (52.0%) currently and/or expect to produce organic acids; 
 (Q6.) 19 companies (38.0%) currently and/or expect to produce bio-based alcohols; 
 (Q8.) 27 companies (54.0%) currently and/or expect to produce bio-based polymers; 
 (Q11.) 14 companies (28.0%) currently and/or expect to produce bio-based composite 
materials; 
 (Q13.) 37 companies (74.0%) currently produce or expect to produce other bio-based 
products.  This category is further disaggregated by subsequent questions  into the following 
sub-categories: 
o (Q14.) 14 companies (28%) currently and/or expect to produce surfactants; 
o (Q15.) 4 companies (8%) currently and/or expect to produce solvents; 
o (Q16.) 7 companies (14%) currently and/or expect to produce binders; 
o (Q17.) 6 companies (12%) currently and/or expect to produce plasticisers; 
o (Q18.) 11 companies (22%) currently and/or expect to produce paints/coatings; 
o (Q19.) 9 companies (18%) currently and/or expect to produce lubricants; 
o (Q20.) 24 companies (48%) currently and/or expect to produce other bio-based 
products (note for further details of specific products currently produced, please 
refer to the analysis of responses to Q20 below). 
 
  
 
Figure A25: Number of companies that currently produce and/or expect to produce bio -based 
products by 2020  
Source: EU bio-based industries survey. 
 
Q5. Please select all the bio-based organic acids which your company currently 
produces, and those which it expects to produce by 2020.  If the product is both 
currently produced and expected to be produced in 2020, please select both columns. 
26 companies indicated that they current produce or expect to produce organic acids 
by 2020.  Figure A26 ranks the type of organic acids that are currently produced or are 
expected to be produced by 2020.  Of this total, 23 companies either currently produce 
and/or expect to produce fatty acids of various types, of which stearic (5 companies), 
oleic (4 companies) and palmitic (3 companies) acids are ranked as the three highest in 
terms of the number of companies indicating current or expected production.  In terms 
of individual products, as illustrated in the chart below, succinic acid (6 companies) is 
ranked highest in terms of the number of companies indicating current or expected 
production; followed by  2,5-furandicarboxylic acid (FDCA) and stearic acid (5 companies 
each); levulinic acid and oleic acid (4 companies each). 
 
26
19
27
14 14
4
7
6
11
9
24
0
5
10
15
20
25
30
O
rg
an
ic
 a
ci
d
s
A
lc
o
h
o
ls
P
o
ly
m
er
s
C
o
m
p
o
si
te
m
at
er
ia
ls
Su
rf
ac
ta
n
ts
So
lv
en
ts
B
in
d
er
s
P
la
st
ic
is
er
s
P
ai
n
ts
/C
o
at
in
gs
Lu
b
ri
ca
n
ts
O
th
er
N
o
. o
f 
co
m
p
an
ie
s
No. of companies that currently produce and/or expect to produce bio-based products by 2020 
(n=50)
  
 
Figure A26: Number of companies that currently produce and/or expect to produce organic acids by 
2020  
Note: * indicates types of fatty acids (23 companies in total). 
Source: EU bio-based industries survey. 
 
Figure A27 shows the expected change in the number of companies currently producing 
different types of organic acids compared to 2020.  The question specifically asked 
respondents to tick both ‘current’ and ‘by 2020’ boxes if they expected to continue 
producing a product in the future.  The results suggest: 
 an increase in the number of companies producing succinic acid, adipic acid, levulinic acid, 
2,5-Furandicarboxylic acid (FDCA), acrylic acid, terephthalic acid, furfural acid and 
methacrylic acid; 
 no change in the number of companies producing formic acid and methyl methacrylate; and 
 a decrease in the number of companies producing lactic acid, acetic acid, lauric acid and 
sebacic acid.  
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Figure A27: Change in the number of companies that currently produce and/or expect to produce 
organic acids by 2020  
Source: EU bio-based industries survey. 
 
Q7. Please select all the bio-based alcohols which your company currently produces, and 
those which it expects to produce by 2020.  If the product is both currently produced 
and expected to be produced in 2020, please select both columns.  
In total 19 companies currently produce bio-based alcohols or expect to product by 
2020.  Figure A28 ranks the type of bio-based alcohols that are currently produced or 
are expected to be produced by 2020.  Of the other top-5 ranked products, fatty 
alcohols (type unspecified) ranked highest in terms of the number of companies 
indicating current or expected production (4 companies); followed by n-butanol, 1,3-
Propanediol (PDO) and Propylene glycol (3 companies each); and isobutanol and 1,4-
Butanediol (BDO) (2 companies each).  4 companies indicated that they either currently 
produce and/or expect to produce ‘other alcohols’ but did not specify products. 
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Figure A28: Number of companies that currently produce and/or expect to produce bio -based 
alcohols by 2020  
Source: EU bio-based industries survey. 
 
Figure A29 shows the expected change in the number of companies currently producing 
different types of bio-based alcohols compared to 2020.  The question specifically asked 
respondents to tick both ‘current’ and ‘by 2020’ boxes if they expected to continue 
producing a product in the future.  The results suggest the number of companies 
producing all types of bio-based alcohols listed is expected to increase by 2020. 
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Figure A29: Change in the number of companies that currently produce and/or expect to produce 
bio-based alcohols by 2020  
Source: EU bio-based industries survey. 
 
Q9. Does your company currently produce bio-based polymers, or expect to produce any 
by 2020? - Derived from natural polymers 
In total 12 companies indicated that they currently produce polymers (derived from 
natural polymers) or expect to produce by 2020. Figure A30Error! Reference source 
ot found. ranks the type of bio-based polymers (derived from natural polymers) that 
are currently produced or are expected to be produced by 2020.  As illustrated, the 
highest ranked product is starch polymers (inc. composites) (7 companies); followed by 
cellulose ether (2 companies); cellulose ester (inc. cellulose acetates) and micro 
fibrillated cellulose (1 company each).  6 companies indicated that they either currently 
produce and/or expect to produce ‘other’ polymers but did not specify products.  
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Figure A30: Number of companies that currently produce and/or expect to produce bio -based 
polymers (derived from natural polymers) by 2020  
Source: EU bio-based industries survey. 
 
Figure A31 shows the expected change in the number of companies currently producing 
different types of bio-based polymers (derived from natural polymers) compared to 
2020.  The question specifically asked respondents to tick both ‘current’ and ‘by 2020’ 
boxes if they expected to continue producing a product in the future.  The results 
suggest: 
 an increase in the number of companies producing cellulose ether and starch polymers (inc. 
composites); while  
 the number of companies producing cellulose ester (inc. cellulose acetates) is expected to 
decrease. 
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Figure A31: Change in the number of companies that currently produce and/or expect to pr oduce 
bio-based polymers (derived from natural polymers) by 2020  
Source: EU bio-based industries survey. 
 
Q10. Does your company currently produce bio-based polymers, or expect to produce 
any by 2020? - Derived from monomers 
In total 25 companies indicated that they currently produce polymers (derived from 
monomers) or expect to produce by 2020. Figure A32 ranks the type of bio-based 
polymers (derived from monomers) that are currently produced or are expected to be 
produced by 2020.  Of the top-5 ranked products, 5 companies indicated that they 
produce or expect to produce polyhydroyalkanoates (PHAs) (inc. PHB), polyamides and 
polylactic acid (PLA); and 4 companies produce or expect to produce polybutylene 
succinate (PBS) and polyesters (inc. formulated polyesters, polyols and resins).. 
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Figure A32: Number of companies that currently produce and/or expect to produce bio -based 
polymers (derived from monomers) by 2020  
Source: EU bio-based industries survey. 
 
Figure A33 shows the expected change in the number of companies currently producing 
different types of bio-based polymers (derived from monomers) compared to 2020.  
The question specifically asked respondents to tick both ‘current’ and ‘by 2020’ boxes if 
they expected to continue producing a product in the future.  The results suggest: 
 an increase in the number of companies producing polyhydroyalkanoates (PHAs), inc. PHB, 
polyurethane (PUR), polylactic acid (PLA), polyethylene furanoate (PEF), polybutylene 
succinate (PBS), polybutyrate (PBAT), polyethylene (PE), polyvinyl chloride (PVC), 
polypropylene (PP) and polyethylene terephthalate (PET); 
 no change in the number of companies producing polycarbonates (PC), polymethyl 
methacrylate (PMMA), polybutadiene (PBD), polybutylene terephthalate (PBT), polystyrene 
(PS) and polyethylene glycol (PEG); and 
 a decrease in the number of companies producing polyamides and polyvinyl acetate (PVA). 
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Figure A33: Change in the number of companies that currently produce and/or expect to produce 
bio-based polymers (derived from monomers) by 2020  
Source: EU bio-based industries survey. 
 
Q12. Please select all the bio-based composite materials which your company currently 
produces, and those which it expects to produce by 2020.  If the product is both 
currently produced and expected to be produced in 2020, please select both columns. 
In total 14 companies indicated that they currently produce bio-based composite 
materials or expect to produce by 2020.  Figure A34 ranks the type of bio-based 
composite materials that are currently produced or are expected to be produced by 
2020.  As illustrated, the highest ranked product is other natural fibre reinforced plastics 
(8 companies); followed by wood-plastic composites (WPC) (6 companies); other 
composite materials (unspecified) (4 companies); and cork reinforced plastics (1 
company). 
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Figure A34: Number of companies that currently produce and/or expect to produce bio -based 
composite materials by 2020  
Source: EU bio-based industries survey. 
 
Figure A35 shows the expected change in the number of companies currently producing 
different types of bio-based composite materials compared to 2020.  The question 
specifically asked respondents to tick both ‘current’ and ‘by 2020’ boxes if they expected 
to continue producing a product in the future.  The results suggest: 
 an increase in the number of companies producing wood-plastic composites (WPC) and 
other natural fibre reinforced plastics; 
 no change in the number of companies producing cork reinforced plastics; and 
 a decrease in the number of companies producing other composite materials (unspecified). 
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Figure A35: Change in the number of companies that currently produce and/or expect to produce 
bio-based composite materials by 2020  
Source: EU bio-based industries survey. 
 
Q14. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Surfactants 
In total 14 companies indicated that they currently produce bio-based surfactants or 
expect to produce by 2020.  Figure A36 ranks the type of bio-based surfactants that are 
currently produced or are expected to be produced by 2020.  9 companies indicated that 
they produce or expect to produce polymeric surfactants; and 5 companies produce or 
expect to produce fatty alcohol ethoxylates/ethers; 4 companies indicated that they 
produce or expect to produce ester quats; and 3 companies each indicated output of 
fatty alcohol ether sulphates, fatty alcohol sulphates and alkyl polyglucosides; while 2 
companies each indicated output of glycolipids (inc. sophorolipids), amphoteric 
surfactants (betaines) and metallic soaps.  
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Figure A36: Number of companies that currently produce and/or expect to produce bio -based 
surfactants by 2020  
Source: EU bio-based industries survey. 
 
Figure A37 shows the expected change in the number of companies currently producing 
different types of bio-based surfactants compared to 2020.  The question specifically 
asked respondents to tick both ‘current’ and ‘by 2020’ boxes if they expected to continue 
producing a product in the future.  The results suggest: 
 an increase in the number of companies producing alkyl polyglucosides and glycolipids (inc. 
sophorolipids); 
 no change in the number of companies producing lipopeptides, digopeptites and polymeric 
surfactants; and 
 a decrease in the number of companies producing fatty alcohol ethoxylates/ethers, fatty 
alcohol ether sulphates, fatty alcohol sulphates, and ester quats. 
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Figure A37: Change in the number of companies that currently produce and/or expect to produce 
bio-based surfactants by 2020  
Source: EU bio-based industries survey. 
 
Q15. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Solvents 
1 company indicated that they currently produce or expect to produce methyl levulinate; 
while 3 companies indicated that they currently produce or expect to produce other 
(unspecified) solvents.  The number of companies that expect to continue producing 
solvents in the future is expected to decrease.  This question produced a small number 
of responses and therefore the results are not presented graphically. 
 
Q16. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Binders 
Figure A38 ranks the type of bio-based binders that are currently produced or are 
expected to be produced by 2020.  As illustrated, 7 companies indicated that they 
produce or expect to produce binders, of which 2 companies each indicated output of 
adhesives and colloid binders; while 1 company each indicated output of pentaerytrithol 
and modified starches and sugar-based binders.  The number of companies that expect 
to continue producing binders in 2020 is expected to decrease slightly.  
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Figure A38: Number of companies that currently produce and/or expect to produce bio -based 
binders by 2020  
Source: EU bio-based industries survey. 
 
Q17. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Plasticisers 
Figure A39  ranks the type of bio-based plasticisers that are currently produced or are 
expected to be produced by 2020.  As illustrated, 6 companies indicated that they 
produce or expect to produce plasticisers, of which 1 company each specified phthalate 
esters, furanoate esters, epoxidized soya bean oil and, isosorbide diester.  The number 
of companies that expect to continue producing binders in 2020 is expected to decrease. 
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Figure A39: Number of companies that currently produce and/or expect to produce bio -based 
plasticisers by 2020  
Source: EU bio-based industries survey. 
 
Q18. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Paints/coatings 
Figure A40 ranks the type of bio-based paints/coatings that are currently produced or 
are expected to be produced by 2020.  As illustrated, 10 companies indicated that they 
produce or expect to produce paint additives; 2 companies produce or expect to produce 
resins (inc. alkyd resins); and 1 company each indicated output of printing colours, 
rheology additives and hybrid polymer coatings.   
The number of companies that expect to continue producing printing colours is expected 
to increase; whereas the number of companies producing paint additives and other 
paints/coatings is not expected to change by 2020.  
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Figure A40: Number of companies that currently produce and/or expect to  produce bio-based 
paints/coatings by 2020  
Source: EU bio-based industries survey. 
 
Q19. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Lubricants 
Figure A41 ranks the type of bio-based lubricants that are currently produced or are 
expected to be produced by 2020.  In total, 9 companies indicated that they produce or 
expect to produce lubricants, with 5 companies each indicating output of mould release 
agents and hydraulic fluids; and 4 companies indicating output of chain & bearing 
lubricants; 2 companies indicating output of additives / raw materials for lubricants; and 
1 company each indicating output of metallic stearates and metal working fluids.   
The number of companies that expect to continue producing mould release agents, chain 
& bearing lubricants and hydraulic fluids in 2020 is expected to decrease; whereas the 
number of other lubricant (unspecified) producers is expected to remain unchanged. 
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Figure A41: Number of companies that currently produce and/or expect to produce bio -based 
lubricants by 2020  
Source: EU bio-based industries survey. 
 
Q20. Does your company currently produce any other bio-based products, or expect to 
produce any by 2020? - Others 
Figure A42 ranks the type of other bio-based products that are currently produced or 
are expected to be produced by 2020.  24 companies indicated that they produce or 
expect to produce ‘other’ bio-based products, of which fatty acid esters constitute the 
most numerous product in the group (6 companies), followed by hydroxymethyl-furfural 
(HMF), fatty amines, ethylene and ethylene glycol (4 companies each; and isosorbide 
and ‘other polymer additives’ (2 companies each).  Other products specified were 
epichlorohydrin, isoprene, farnesene, para-xylene, chelating agents, carbon nanotubes 
(from ethanol), limonene, lignosulphonates, acetaldehyde, ethyl acetate and fatty acid 
amides. 
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Figure A42: Number of companies that currently produce and/or expect to produce other bio -based 
products by 2020  
Source: EU bio-based industries survey. 
 
Figure A43 shows the expected change in the number of companies currently producing 
different types of other bio-based products compared to 2020.  The question 
specifically asked respondents to tick both ‘current’ and ‘by 2020’ boxes if they expected 
to continue producing a product in the future.  The results suggest: 
 an increase in the number of companies producing hydroxymethyl-furfural (HMF), isoprene, 
farnesene, ethylene, ethylene glycol and para-xylene; 
 no change in the number of companies producing isosorbide, fatty amines and acetone; and 
 a decrease in the number of companies producing epichlorohydrin and other (unspecified) 
products. 
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Figure A43: Change in the number of companies that currently produce and/or expect t o produce 
other bio-based products by 2020  
Source: EU bio-based industries survey. 
 
2. Company information 
Q21. What is the ownership structure of your company?  
Public limited liability company:  15 (31.3%) 
Private limited liability company:  32 (66.7%) 
Other (not-for-profit):   1 (2.1%) 
Answered question:    48 
 
Q22. Is your company a subsidiary of a larger company? 
Yes:      16 (33.3%) 
No:      32 (66.7%) 
Answered question:    48 
 
Q23. Is your company a joint venture with another company? 
Yes:      5 (10.6%) 
No:      42 (89.4%) 
Answered question:    47 
 
3. Production facilities in EU Member States 
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Q24-26. Does your company have bio-based production facilities in the EU? 
42 companies indicated that they have bio-based production facilities in the EU, of which 
41 companies provided information on 100 separate plants.  Of this total: 
 16 are pilot plants; 
 10 are demonstration plants; 
 73 are commercial (active) plants; and 
 1 is a commercial (dormant1) plant. 
Figure A44 presents the status and location of bio-based production facilities in the EU 
based on the survey responses.  The largest numbers of plants are located in Italy (18), 
Germany (16), France (15), Netherlands (10) and Spain (9).  Germany has the largest 
number of commercial (active) plants (16), whereas Italy has the largest number of pilot 
and demonstration plants (8).   
 
 
Figure A44: Status and location of bio-based production facilities in the EU  
Source: EU bio-based industries survey. 
 
Q27. What were the key reasons for selecting the location of the facilities listed above? 
Figure A45 below ranks reasons for selecting the location of bio-based production 
facilities in the EU.  In total, 35 companies responded to the question, indicating that the 
two main factors for site selection are feedstock availability (17 responses) and 
proximity to existing commercial activity (17 responses), followed by proximity to R&D 
                                           
1  i.e. not currently active; but with expectation of resuming activities when market 
conditions are favourable. 
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activities (16 responses), proximity to customer demand (11 responses) and 
infrastructure (11 responses). 
 
 
Figure A45: Key reasons for selecting the location of bio-based production facilities in the EU  
Source: EU bio-based industries survey. 
 
4. Production facilities outside the EU 
Q28-30. Does your company have bio-based production facilities outside the EU? 
21 companies indicated that they have bio-based production facilities outside the EU, of 
which 18 companies provided information on 41 separate plants.  Of this total: 
 1 is a pilot plant; 
 None are demonstration plants; 
 39 are commercial (active) plants; and 
 1 is a commercial (dormant2) plant. 
Figure A46 presents the status and location of bio-based production facilities outside the 
EU.  The largest number of plants are located in Asia (17) and North America (17), 
followed by South & Central America (4), Africa (2) and Other (non-EU) Europe (1).   
In terms of countries, the USA has the largest number of plants (15), followed by China 
(5), Brazil (3), Malaysia (3) and Singapore (3). 
 
                                           
2  i.e. not currently active; but with expectation of resuming activities when market 
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Figure A46: Status and location of bio-based production facilities outside the EU  
Source: EU bio-based industries survey. 
 
Q31. What were the key reasons for selecting the location of the facilities listed above? 
Figure A47 below ranks reasons for selecting the location of bio-based production 
facilities outside the EU.  In total, 16 companies responded to the question, indicating 
that the main factor for site selection is feedstock availability (10 responses); followed 
by proximity to existing commercial activity (8 responses); proximity to customer 
demand and R&D activities (7 responses each); followed by both policy and regulation 
and feedstock cost (5 responses each). 
 
1
2
17 15
1
4
1
0
2
4
6
8
10
12
14
16
18
Africa Asia North America Other Europe (non-EU) South & Central
America
N
o
. o
f 
co
m
p
an
ie
s
Status and location of bio-based production facilities outside the EU  (n=18)
Pilot Demonstration Commercial (Active) Commercial (Dormant)
  
 
Figure A47: Key reasons for selecting the location of bio-based production facilities outside the EU  
Source: EU bio-based industries survey. 
 
5. Industry associations 
Q32-34. Is your company a member of any chemical or bio-based industry association? 
44 companies indicated that they are members of chemical or bio-based industry 
associations.  Of this total, 40 companies are members of EU associations and 34 are 
members of Member State associations. 
Figure A48 illustrates membership of EU chemical or bio-based industry associations.  In 
terms of representing companies which responded to the survey, the 5 EU associations 
with the largest membership are:  
 BIC - Bio-based Industries Consortium (20); 
 Cefic - European Chemical Industry Council (19); 
 EuropaBio - European Association for Bio-industries (11); 
 APAG - European Oleochemicals and Allied Products Group Plastics Europe (9); 
 Plastics Europe (8). 
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Figure A48: Companies indicating membership of EU chemical or bio-based industry associations  
Source: EU bio-based industries survey. 
 
Figure A49 illustrates membership of Member State chemical or bio-based industry 
associations.  In terms of representing companies which responded to the survey, the 5 
Member State associations with the largest membership are:  
 DE - VCI - Verband der Chemischen Industrie e.V. (8); 
 IT - FEDERCHIMICA - Federazione Nazionale dell'Industria Chimica (8); 
 FR - UIC - Union des Industries Chimiques (6); 
 NL - VNCI - Vereniging van de Nederlandse Chemische Industrie (6); 
 UK - CIA - Chemical Industries Association (6). 
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Figure A49: Companies indicating membership of Member State chemical or bio-based industry 
associations  
Source: EU bio-based industries survey. 
 
6. Research and development 
Q35. Does your company carry out R&D activities related to bio-based products in the 
EU? 
Yes:    43 (89.6%) 
No:    5 (10.4%) 
Answered question:  48 
 
Q36-37. Does your company carry out R&D activities related to bio-based products 
outside the EU? 
19 companies stated that the carry out R&D activities related to bio-based products 
outside the EU.  Of this total, 18 provided details of the location of these activities: 
 13 companies have R&D activities in North America; 
 13 companies have R&D activities in Asia; 
 3 companies have R&D activities in Other (non-EU) Europe; 
 2 companies have R&D activities in South & Central America;  
 1 company has R&D activities in Africa; and 
 no companies have R&D activities in Oceania. 
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Q38-39. From the list, please indicate the importance of the following DRIVERS for the 
development of bio-based products by your company.  
Figure A50 presents an assessment of the relative importance of drivers for the 
development of bio-based products.  In total, 45 companies responded to the question, 
indicating that the most important drivers are improved product competitiveness (42 
companies), sales growth potential (40 companies), improved profitability (40 
companies), development of innovative products (39 companies) and improved product 
properties or performance (38 companies).  Companies were also asked to provide 
supplementary information on other factors which they deemed important.  Such factors 
included ‘strong customer requests’ and ‘private funding’ (1 company each).  However, 
respondents were not asked to categorise the importance of these factors and therefore 
these responses are not included in Figure A50 below. 
 
 
Figure A50: Drivers for the development of bio-based products 
Source: EU bio-based industries survey. 
 
When asked further to select the three most important drivers for the development of 
bio-based products, out of 44 companies which responded to the question, the three 
most important drivers selected were improved profitability (18 companies), improved 
product competitiveness (18 and development of innovative products (18 companies); 
followed by improved environmental performance (13 companies) and sales growth 
potential (12 companies).  These results are presented in Figure A51 and broadly 
confirm the findings above.  
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Figure A51: Ranking the most important drivers for the development of bio -based products 
Source: EU bio-based industries survey. 
 
8. Constraints on development of bio-based products 
Q40-41. From the list, please indicate the importance of the following CONSTRAINTS on 
the development of bio-based products by your company 
Figure A52 presents an assessment of the relative importance of constraints for the 
development of bio-based products.  In total, 46 companies responded to the question, 
indicating that the most important constraints are higher production costs (25 
companies); availability of funds to invest in production capacity (17 companies) and 
increased or variable feedstock costs (17 companies); availability of funds for necessary 
R&D (16 companies); followed by technology maturity (10 companies) and product 
properties or performance (10 companies).  Companies were also asked to provide 
supplementary information on other factors which they deemed important.  Such factors 
included ‘competition with bio-energy sectors’ and ‘feedstock availability (competition, 
quality, etc.)’ (3 companies each); as well as ‘lack of legislative support’, ‘customer 
demand’ and ‘supply chain costs’ (1 company each). However, respondents were not 
asked to categorise the importance of these factors and therefore these responses are 
not included in Figure A52 below.  
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Figure A52: Constraints on the development of bio-based products 
Source: EU bio-based industries survey. 
 
When asked further to select the three most important constraints on the development 
of bio-based products, out of 46 companies which responded to the question, the three 
most important constraints selected were higher production costs (27 companies), 
increased or variable feedstock costs (23 companies), availability of funds to invest in 
production capacity (19 companies).  These results are presented in Figure A53 and 
broadly confirm the findings above.  
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Figure A53: Ranking the most important constraints on the development of bio -based products 
Source: EU bio-based industries survey. 
 
9. EU employees 
Q42. What was the total number of employees in your company in the EU? 
In total, 42 companies responded to the question providing data on the number of 
employees between 2010 and 2013, although not all companies provided data for each 
year. Table A3 presents the total number of employees identified in each year and the 
number of companies which provided data for that year.  
 
Table A3: Number of staff employed by bio-based companies in the EU between 2010 and 2013  
2010 2011 2012 2013 
109,805 110,346 189,729 220,056 
n = 30 n = 30 n = 34 n = 42 
Source: EU bio-based industries survey. 
 
Q43. What share (%) was employed in bio-based activities in the EU? 
35 companies provided data on the proportion of total employees employed in bio-based 
activities (Table A4).  Cross tabulation of this data with the data on total employment 
numbers was used to estimate the total number of employees in bio-based activities and 
to calculate the annual increase in total employment (Table A5).   
 
27
23
19
13 13
9 9
6 6
3
2 2
0
5
10
15
20
25
30
H
ig
h
er
 p
ro
d
u
ct
io
n
 c
o
st
s
In
cr
ea
se
d
 o
r 
va
ri
ab
le
 f
ee
d
st
o
ck
 c
o
st
s
A
va
ila
b
ili
ty
 o
f 
fu
n
d
s 
to
 in
ve
st
 in
p
ro
d
u
ct
io
n
 c
ap
ac
it
y
A
va
ila
b
ili
ty
 o
f 
fu
n
d
s 
fo
r 
n
ec
es
sa
ry
R
&
D
Te
ch
n
o
lo
gy
 m
at
u
ri
ty
In
cr
ea
se
d
 c
ap
it
al
 c
o
st
s
P
ro
d
u
ct
 p
ro
p
er
ti
es
 o
r 
p
er
fo
rm
an
ce
In
cr
ea
se
 e
n
er
gy
 d
em
an
d
 a
n
d
/o
r 
co
st
O
th
er
 (
u
n
sp
ec
if
ie
d
)
B
ar
ri
e
rs
 t
o
 a
ch
ie
vi
n
g 
p
ro
d
u
ct
ce
rt
if
ic
at
io
n
O
th
er
 o
p
er
at
io
n
al
 c
o
st
s
Ex
is
ti
n
g 
p
at
en
ts
, o
r 
o
th
er
 IP
 is
su
es
N
o
. o
f 
co
m
p
an
ie
s
Ranking the most important constraints on the development of bio-based products (n=46)
  
Table A4: Proportion of total employees engaged in bio-based activities (No. of companies)  
 Number of companies 
Proportion of 
employees in 
bio-based 
activities 2010 2011 2012 2013 
>50% 11 12 14 19 
25% to 49% 1 1 1 2 
10% to 24% 4 5 4 6 
<10% 10 7 8 8 
Source: EU bio-based industries survey. 
 
Table A5: Increase in the number of employees engaged in bio-based activities  
Increase in number of employees 
2010 2011 2012 2013 
- 987 357 2,334 
- n = 26 n = 28 n = 36 
Source: EU bio-based industries survey. 
 
Q44. What share (%) was involved in R&D activities related to bio-based products in the 
EU? 
32 companies provided data on the proportion of total employees involved in R&D 
activities related to bio-based products (Table A6).  Cross tabulation of total employment 
numbers with the proportion of total employees involved in R&D activities related to bio-
based products in the EU was used to estimate the total number of employees involved 
in R&D activities related to bio-based products (Table A7).  
 
Table A6: Proportion of total employees engaged in bio-based R&D activities (No. of companies) 
 Number of companies 
Proportion of 
employees in 
bio-based R&D 
activities 2010 2011 2012 2013 
>50% 5 4 7 8 
25% to 49% 2 4 4 5 
10% to 24% 3 2 1 4 
<10% 15 13 13 14 
Source: EU bio-based industries survey. 
 
  
Table A7: Increase in the number of employees engaged in bio-based R&D activities 
2010 2011 2012 2013 
- 87 312 3,237 
- n = 25 n = 27 n = 33 
Source: EU bio-based industries survey. 
 
10. Production 
Q46. What was your company’s total annual output (in tonnes) of bio-based products in 
the EU? 
Table A8 presents average and total annual output (in tonnes) of bio-based products in 
the EU.  27 companies responded to this question, of which 21 provided data in each of 
the 4 years requested (2010, 2011, 2012, 2013) and the average and total output 
figures presented here are based on these 24 companies. Reported production output 
has remained relatively flat over the time period.   
 
Table A8: Average and total output of bio-based products in the EU 
Answer Options Average1 Total2 
2010 - (in tonnes) 31,963 671,223 
2011 - (in tonnes) 47,368 994,734 
2012 - (in tonnes) 42,669 896,053 
2013 - (in tonnes) 55,964 1,175,235 
Note: 1 Simple average and 2 total (sum) for companies which provided data for all years (2010, 2011, 2012, 
2013).  
Source: EU bio-based industries survey. 
 
Q47. What share (%) of EU bio-based product output was sold in the EU? 
Figure A54 presents the average share of total EU bio-based output sold in the EU over 
the period from 2010 to 2013.  The proportion of EU output sold within the EU declined 
from 86.2% in 2010 to 83.2% in 2012, before increasing to 89.8% in 2013. Table A9 
presents the proportion of EU bio-based product output sold within the EU. This decline 
in the percentage of bio-based output sold in the EU is more than compensated for by 
the increase in total production, indicating that the European market is also growing.  
 
  
 
Figure A54: Proportion of EU bio-based product output sold within the EU 
Source: EU bio-based industries survey. 
 
Table A9: Proportion of EU bio-based product output sold within the EU (number of companies)  
Proportion  of 
employees 2010 2011 2012 2013 
>75% 13 12 12 13 
50% to 74% 2 2 1 2 
25% to 49% 0 0 1 2 
1% to 24% 0 0 0 0 
0% 7 7 8 9 
Source: EU bio-based industries survey. 
 
Q48. How is the share (%) of bio-based product output sold in the EU expected to 
change by 2020? 
37 companies indicated their expectation for how the share (%) of bio-based product 
output sold in the EU expected to change by 2020 (see Figure A55): 
 15 companies expect the share of sales in the EU to increase >100%;  
 13 companies expect the share of sales in the EU to increase <100%; 
 8 companies expect no change in the share of sales in the EU; 
 1 company expect the share of sales in the EU to Decrease; 
 no companies expect the share of sales in the EU to Decrease to zero. 
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Figure A55: Expected change in the share (%) of EU bio-based product output sold within the EU by 
2020 
Source: EU bio-based industries survey. 
 
11. Feedstock 
Q45. What types of processes does your company use for the production of bio-based 
products in the EU? 
Figure A56 presents the types of feedstock conversion processes used for the production 
of bio-based products in the EU.  40 companies provided information on the types of 
feedstock processes used.  As illustrated, 17 companies use catalytic conversion 
processes, 15 use fermentation and 6 use enzymatic conversion processes.  25 
companies state that they use other processes, mainly different types of chemical 
reactions/conversion, e.g. polymerisation, hydrolysis, esterification and pyrolysis.  
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Figure A56: Types of feedstock conversion processes used for the production of bio -based products in 
the EU 
Source: EU bio-based industries survey. 
 
Answers to questions 45 and 49-55 are not uniquely linked; in other words, if a 
respondent identifies multiple feedstocks in questions 49-55 and multiple processes in 
question 45, it is not possible to separate out which process is used for each feedstock; 
consequently cross-tabbing of multiple answers creates links between feedstocks and 
processes which, in reality are not relevant for the company.  
 
Q49. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Fibres 
11 companies state that they use various forms of fibre as feedstock for bio-based 
products in the EU, of which 8 companies use wood and 2 use chemical pulp.  Figure A57 
illustrates the number of companies using different fibre feedstocks over the period from 
2010 to 2013. 
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Figure A57: Number of companies using fibre feedstocks 
Source: EU bio-based industries survey. 
 
Q50. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Sugars 
Figure A58 illustrates the number of companies using sugar feedstocks over the period 
from 2010 to 2013.  In total, 9 companies state that they use various sugar feedstocks 
for bio-based products in the EU, of which 6 companies use sugar beet, 5 use sugar cane 
and 3 use other sugars3 (including xylose and arabinose, synthetic sugars (C5 and C6), 
corn (HFS), dextrose and ligno-cellulosic sugars).   
 
                                           
3 Note: the question was designed to allow respondents to specify the types of ‘other 
sugar’, but not to allocate use to specific years.  
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Figure A58: Number of companies using sugar feedstocks 
Source: EU bio-based industries survey. 
 
Q51. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Starch 
Figure A59 illustrates the number of companies using starch feedstocks for bio-based 
products in the EU over the period from 2010 to 2013.  15 companies state that they 
use various forms of starch, of which maize (10 companies), wheat (7 companies), 
potato (3 companies), cassava (1 company) and other starch (1 company, which 
specified rice starch feedstock).   
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Figure A59: Number of companies using starch feedstocks 
Source: EU bio-based industries survey. 
 
Q52. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Vegetable oils 
Figure A60 illustrates the number of companies using vegetable oil feedstocks for bio-
based products in the EU over the period from 2010 to 2013.  19 companies state that 
they use various forms of starch, of which rapeseed oil (11 companies), palm oil (10 
companies), coconut oil (8 companies), soybean oil (7 companies) and linseed oil (3 
companies).  12 companies indicate that they use other vegetable oils4 (e.g. palm kernel 
oil, castor oil, sunflower oil and microalgae oil). 
  
                                           
4 Note: the question was designed to allow respondents to specify the types of ‘other 
vegetable oils’, but not to allocate use to specific years.  
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Figure A60: Number of companies using vegetable oil feedstocks 
Source: EU bio-based industries survey. 
 
Q53. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Residues 
Figure A61 illustrates the number of companies using residue feedstocks for bio-based 
products in the EU over the period from 2010 to 2013.  19 companies state that they 
use various residues, of which animal fats (10 companies) and agricultural residues (7 
companies).  5 companies indicate that they use other residues5 (e.g. bagasse, bran and 
beet pulp, cellulose residues; soy protein and tallow). 
 
                                           
5 Note: the question was designed to allow respondents to specify the types of ‘other 
residues’, but not to allocate use to specific years.  
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Figure A61: Number of companies using residue feedstocks 
Source: EU bio-based industries survey. 
 
Q54. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Alcohols 
Figure A62 illustrates the number of companies using alcohol feedstocks for bio-based 
products in the EU over the period from 2010 to 2013.  14 companies state that they 
use various alcohols, of which glycerol (9 companies) and bio-ethanol (7 companies).  4 
companies indicate that they use other alcohols6 (e.g. amylic alcohol, octyl alcohol, decyl 
alcohol and fatty alcohols C8-C22). 
 
                                           
6 Note: the question was designed to allow respondents to specify the types of ‘other 
alcohols’, but not to allocate use to specific years.  
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Figure A62: Number of companies using alcohol feedstocks 
Source: EU bio-based industries survey. 
 
Q55. What type(s) of feedstock does your company use to produce bio-based products 
in the EU? - Other  
Figure A63 illustrates the number of companies using other feedstocks for bio-based 
products in the EU over the period from 2010 to 2013.  7 companies state that they use 
other feedstocks7, including lignocellulose, brown liquor from sulphite pulping, sebatic 
acid, fatty acids C8-C24, shells and sugar based lactides. 
 
                                           
7 Note: the question was designed to allow respondents to specify the types of ‘other 
feedstocks’, but not to allocate use to specific years.  
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Figure A63: Number of companies using other feedstocks not previously captured  
Source: EU bio-based industries survey. 
 
Q56. What share (%) of bio-based feedstock is sourced from within the EU (i.e. 
feedstock of EU origin)? 
Figure A63 presents the average share of bio-based feedstock sourced from within the 
EU over the period from 2010 to 2013.  As can be seen, the share increased from 71% 
in 2010 to 72% in 2011, before declining to 67% in 2013.  
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Figure A64: Proportion of bio-based feedstock sourced from within the EU 
Source: EU bio-based industries survey. 
 
Q57. What is the share (%) of bio-based feedstock in total feedstock use for producing 
bio-based products in the EU? 
Figure A65 presents the average share of bio-based feedstock in total feedstock use for 
producing bio-based products in the EU over the period from 2010 to 2013.  The share 
has increased steadily from 64% in 2010 to 68% in 2013.  
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Figure A65: Proportion of bio-based feedstock in total feedstock use  
Source: EU bio-based industries survey. 
 
Q58. How is the contribution of bio-based feedstock to total feedstock use likely to 
change by 2020? 
36 companies indicated their expectation for how the contribution of bio-based feedstock 
to total feedstock use likely to change by 2020 (Figure A66): 
 9 companies expect the contribution to increase >100%;  
 16 companies expect the contribution to increase <100%; 
 11 companies expect no change in contribution; 
 no companies expect the contribution to decrease; 
 no companies expect the contribution to decrease to zero. 
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Figure A66: Expected change in the share (%) of bio-based feedstock in total feedstock use by 2020 
Source: EU bio-based industries survey. 
 
12.  Sales turnover 
Q59. What was your company’s total sales turnover of bio-based products worldwide (in 
Euros)? 
In total, 24 companies responded to the question providing data on total sales turnover 
of bio-based products worldwide between 2010 and 2013. The total sales turnover for 
bio-based products for all companies is presented in Table A10.  Table A11 presents an 
analysis of average sales turnover of bio-based products worldwide. 
 
Table A10: Total sales turnover of bio-based products (Million euros) 
2010 2011 2012 2013 
2,636.5 2,819.4 2,858.4 6,812.4 
n = 19 n = 19 n = 20 n = 24 
 
 Table A11: Average sales turnover of bio-based products by size category (Million euros) 
 2010 2011 2012 2013 
>€50m 286.6 306.1 309.4 612.3 
€10-50m 26.5 20.8 23.3 23.7 
€2-10m 3.0 2.4 3.5 5.0 
<€2m 1.2 0.0 0.0 0.0 
Source: EU bio-based industries survey. 
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Q61. What was your company’s total sales turnover in the EU (i.e. fossil-based and bio-
based products) (in Euros)? 
27 companies responded to the question providing data on total sales turnover (fossil 
and bio-based products) in the EU between 2010 and 2013.  The total sales turnover for 
bio-based products for all companies is presented in Table A12. Table A13 present an 
analysis of average sales turnover in the EU. 
 
Table A12: Total sales turnover in the EU (Million euros) 
2010 2011 2012 2013 
27,329 31,051 60,343 63,290 
n = 19 n = 20 n = 22 n = 27 
 
Table A13: Average sales turnover in the EU by size category (Million euros) 
 2010 2011 2012 2013 
>€50m 2,484 2,588 4,642 3,956 
€10-50m 35.0 35.0 35.0 35.0 
€2-10m 2.7 2.6 3.1 3.7 
<€2m 0.8 0.3 0.4 0.4 
Source: EU bio-based industries survey. 
 
Q62. What was your company’s total sales turnover of bio-based products in the EU (in 
Euros)? 
23 companies responded to the question providing data on total sales turnover of bio-based 
products sold in the EU between 2010 and 2013. The total sales turnover for bio-based products for 
all companies is presented in Table A14.  
Table A15 presents an analysis of average sales turnover of bio-based products in the 
EU. 
 
Table A14: Total sales turnover for bio-based products in the EU (Million euros) 
2010 2011 2012 2013 
846 1,052 1,040 1,378 
n = 17 n = 18 n = 19 n = 23 
  
 
Table A15: Average sales turnover of bio-based products in the EU by size category (Million euros) 
 2010 2011 2012 2013 
>€50m 141.0 150.3 148.5 153.1 
€10-50m 23.5 19.0 20.7 22.3 
€2-10m 3.0 0.0 0.0 2.0 
<€2m 0.6 0.9 1.0 0.4 
Source: EU bio-based industries survey. 
 
Q60. How is total sales turnover of bio-based products worldwide expected to change by 
2020? 
34 companies indicated their expectation for how sales turnover of bio-based products 
worldwide expected to change by 2020 (see Figure A67): 
 19 companies expect sales worldwide to increase >100%;  
 12 companies expect sales worldwide to increase <100%; 
 3 companies expect no change in sales worldwide; 
 no companies expect sales worldwide to decrease; 
 no companies expect sales worldwide to decrease to zero. 
 
Q63. How is total sales turnover of bio-based products in the EU expected to change by 
2020? 
33 companies indicated their expectation for how sales turnover of bio-based products in 
the EU is expected to change by 2020 (Figure A67): 
 17 companies expect sales in the EU to increase >100%;  
 14 companies expect sales in the EU to increase <100%; 
 2 companies expect no change in sales in the EU; 
 no companies expects sales in the EU to decrease; 
 no companies expect sales in the EU to decrease to zero. 
 
  
 
Figure A67: Expected change in sales turnover of bio-based products worldwide and in the EU by 
2020 
Source: EU bio-based industries survey. 
 
13. Costs 
Q64-67. What was the approximate contribution (%) of each of the following categories 
to production costs for bio-based products produced in the EU?  
The average contribution (%) of various cost categories to production costs for bio-
based products produced in the EU are broken down as follows: 
 Feedstock:  46% 
 Labour:   12% 
 Utilities:  9% 
 Other OPEX:  7% 
 R&D:   4% 
 CAPEX:   7% 
 Other (balance): 15% 
 
14. Public funding 
Q68. Has your company received public funding since 2010? 
Yes:    25 (55.6%) 
No:    20 (44.4%) 
Answered question:  45 
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Q69. What was the total value (in Euros) of public funding received? 
17 companies provided data on the value of public financing received over the period 
from 2010 to 2013.  Table A16 presents average and total values for the companies 
which provided information.  
 
Table A16: Average and total value of public financing received over the period from 2010 to 2013  
 Average Total No of Respondents 
2010 - (in Euros)  1,883,417   22,601,000  12 
2011 - (in Euros)  2,069,735   24,836,819  12 
2012 - (in Euros)  1,848,334   25,876,674  14 
2013 - (in Euros)  2,892,776   46,284,418  16 
Source: EU bio-based industries survey. 
 
Q70. What was the name(s) of the programme from which public funding was received? 
20 companies provided information on the various sources of national and EU public 
funding, e.g.: 
 Bandi MIUR-MISE; Bandi Regionali; BioCore (FP7) 
 Câmara Municipal; Ciência Viva  
 EOS-LT; EU FP7; EuroBioRef (FP7), ERA-NET IB; Energy 
 FEDER; Finnish Ministry; FR (AII -now BPI); Fundo Florestal Permanente 
 Instituto do Emprego e Formação Profissional; Italian Industria 2015; IWT 
 KBBE 
 Marie Curie; MKB Innovatie Programma 
 National and transnational funding schemes; NMP 
 Poli d'Innovazione; People; PON 
 QREN - Quadro de Referência de Estratégia Nacional 
 RDA (NL) 
 Structural funds 
 TEKES; Term Pilot facilities; Topsector ENergie 
 Ultrafibre 
 Valorization of non-food feedstock in valuable chemicals; Vinnova Skogskemi  
 WBSO 
 
Q71. Did this derive from an ‘EU Framework Programme’? 
Table A17 provides information on whether the source of public funding received over 
the period from 2010 to 2013 included funding from an ‘EU Framework Programme’. 
 
  
Table A17: Companies that received funding from an ‘EU Framework Programme’  
Answer Options Yes No Don't know 
2010 5 9 1 
2011 6 9 1 
2012 5 10 1 
2013 9 8 1 
 
  
  
Annex IV: Detailed analysis of products indicated in the survey 
responses 
The survey collected information from 50 companies on the types of products produced 
(Figure A68). As reported in the figure, the bio-based products indicated by most 
respondents are organic acids, polymers (obtained from bio-based monomers) and 
surfactants. If we compare the products currently produced with the ones expected to be 
produced in 2020, there is a general growing trend in terms of number of products, but 
not concerning all products.  
Based on the survey responses, 27 companies currently produce or expect to produce 
bio-based polymers by 2020, 26 companies currently produce or expect to produce 
organic acids by 2020, 19 companies currently produce or expect to produce bio-based 
alcohols by 2020, and 14 companies currently produce or expect to produce bio-based 
composites by 2020. Within the bio-based polymers, 25 companies indicated that they 
currently produce or expect to produce bio-polymers from monomers by 2020, and 12 
companies indicated that they current produce or expect to produce bio-based polymers 
from natural polymers by 2020. 37 companies currently produce or expect to produce 
other bio-based products by 2020, including surfactants (14), paints and coatings (11), 
lubricants (9), binders (7), plasticisers (6), and solvents (4).  
 
Figure A68: Number of companies that currently produce and/or expect to produce bio -based 
products by 2020  
Source: EU bio-based industries survey. 
Note: 50 respondents. 
If we count both the currently produced and the expected bio-based products, 284 
products have been indicated in total by the 50 respondents (i.e. between 5 and 6 per 
company in average). While some companies only indicated 1-2 products, others 
indicated up to 20 products, and often belonging to different product categories. This 
variety makes the overall data analysis very complex, since most indicators have been 
asked for the whole bio-based sector within the company, and not specifically per 
product. 
The most frequently indicated products are illustrated in  Bio-based products most 
frequently indicated by the survey respondents. 
69, which presents the number of companies that currently produce or expect to 
produce the product by 2020. This includes a range of speciality (or functional) 
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chemicals, oleochemicals, polymers, and chemical building blocks. Many of these are 
established products, such as fatty acids and fatty acid esters, paint additives, polymeric 
surfactants, starch polymers, and wood –plastic composites. However, a number of 
these products currently have few producers, but more companies report that they 
expect to begin production by 2020. For PBS and HMF, no current producers were 
identified but four companies indicated they expect to produce by 2020. For FDCA and 
PHAs, two companies indicated that they currently produce these products, and five 
companies indicated that they expect to produce these products in 2020. In addition, 
three companies expect to begin production of levulinic acid, n-butanol and propylene 
glycol by 2020.  
 
Figure A69: Bio-based products most frequently indicated by the survey respondents.  
Source: EU bio-based industries survey. 
 
For each product category, the tables below show the distribution of responses between 
what is currently produced and what is expected for 2020.  
Organic acids 
According to Table A18, succinic acid, FDCA and levulinic acid are promising bio-based 
organic acids, for the current and future (2020) market. Other products indicated as 
promising 2020 candidates are adipic acid and furfural. The use and production process 
of these products is described in Box 1. The future potential of these products is 
confirmed also by the fact that the companies indicating them also show a growing trend 
in total annual output of bio-based products in the EU and are expecting the share of 
bio-based product output sold in the EU to increase by 2020 (according to their answers 
to the survey). The table also shows products that are currently produced but for which 
no growing trends was detected for 2020 in terms of new companies entering the 
market.  
Many new bio-based products were indicated outside the list provided in the 
questionnaire. In particular, a long list of fatty acids was indicated by, in total, 11 
respondents as products not described in the initial list. Certain companies have 
indicated that they will start the production of certain (unspecified) fatty acids only by 
2020.  
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Table A18: Responses distribution about the production of bio-based organic acids.  
Organic acids Total companies 
indicating the 
product as current or 
expected 
New companies 
entering the 
market in 2020 
Succinic acid 6 2 
2,5-Furandicarboxylic acid (FDCA) 5 3 
Levulinic acid 4 3 
Lactic acid 3 1 
Acetic acid 3 1 
Sebacic acid 3 0 
Adipic acid 2 2 
Furfural 2 2 
Formic acid 2 1 
Lauric acid 2 0 
Acrylic acid 1 1 
Terephthalic acid 1 1 
Methacrylic acid 1 1 
Methyl methacrylate 1 0 
Other (outside the intial list) 14 3 
 Fatty acids and derivates, including partly hydrogenated fatty acids and fatty 
acids from rapeseed, soybean, palm, shea and tallow. In particular: hexanoic 
acid, heptanoic acid, caprylic acid, pelargonic acid, decanoic acid, C11 fatty 
acids, undecenoic acid, palmitic acid, stearic acid and fractionated stearic 
acids, oleic acid and more C16 – 18, both saturated and unsaturated 
 Azelaic acid 
Source: EU bio-based industries survey. 
Alcohols 
According to Table A19, all bio-based alcohols initially proposed in the survey list are 
showing a growing trend towards 2020 in terms of new players entering the field and 
planning to start producing them by 2020. According to the collected data, the most 
promising bio-based alcohols for the current and future (2020) market are n-butanol, 
propylene glycol, 1,3-propanediol (PDO) and 1,4-butanediol (BDO), which are described 
in Box 2. 
Outside the list provided in the questionnaire, several bio-based fatty acid alcohols were 
indicated by the respondents. Two companies indicated that they will start fatty alcohols 
production only by 2020.  
 
  
  
Table A19: Responses distribution about the production of bio-based alcohols 
Bio-based alcohols Total companies 
indicating the 
product as 
current or 
expected 
New 
companies 
entering the 
market in 
2020 
n-butanol 3 3 
Propylene glycol 3 3 
1,3-Propanediol (PDO) 3 2 
1,4-Butanediol (BDO) 2 2 
Isobutanol 2 1 
Furfuryl alcohol 1 1 
Methanol 1 1 
Other 8 2 
 Fatty Alcohols: 2-octanol, Heptanol, Oleyl Alcohol, Cetyl Oleyl Alcohol, 
Decanol, Dododecanol, Tetradecanol, Hexadecanol 
Source: EU bio-based industries survey. 
 
 
  
 
 
Polymers 
Polymers are classified in two main groups: polymers derived from natural polymers 
(like starch and cellulose) and polymers obtained from bio-based monomers (like e.g. 
organic acids and alcohols). According to survey respondents, among natural polymers 
the most promising are starch polymers, indicated by seven companies, of which three 
are planning to enter the market by 2020 (Table A20). 
The list of polymers obtainable from bio-based monomers is very long (Table A20), the 
most promising being PHAs (which include several different polymers), PLA and PBS. 
They are described in more details in Box 3. Respondents also indicated additional 
BOX2 – Promising Bio-based Alcohols 
 
n-butanol 
n-butanol is an important chemical building block, particularly for the manufacture of butyl acetate, and 
therefore has uses as solvent in paints and coatings for wood products, but also appearing as food 
flavouring. Most industrial initiatives in the field of n-butanol are aimed at the biofuels market due to 
better properties of n-butanol compared to ethanol. 
The production of n-butanol has historically taken place via acetone, through the acetone (ABE) or 
isopropanol (IBE), butanol and ethanol fermentation. However, it became more economically convenient 
to produce n-butanol chemically via fossil propylene. Currently, many companies are active to re-
introduce the ABE or IBE process commercially again, particularly in China. 
Propylene glycol 
45% of propylene glycol produced is used as chemical feedstock for the production of unsaturated 
polyester resins. It is used as a humectant (E1520), solvent, preservative in food and for tobacco products, 
as well as in electronic cigarettes. Propylene glycol is also used as a solvent in many pharmaceuticals.  
Industrially, propylene glycol is produced from propylene oxide. Bio-based propylene glycol is currently 
obtained from starch and sugars (like sorbitol and dextrose) or from glycerol. 
1,3-Propanediol (PDO) 
1,3-propanediol is the promising bulk chemical which has attracted worldwide attention due to its 
enormous applications in polymers (such as polytrimethylene terephthalate - PTT), cosmetics, foods, 
adhesives, lubricants, laminates, solvents, antifreeze and medicines. 
The majority of commercial synthesis of 1,3-propanediol are through the hydration of acrolein and 
through the hydroformylation of ethylene oxide to afford 3-hydroxypropionaldehyde. Its microbial 
production is based on glucose or on glycerol, which promises to be a good substrate being a major by-
product of the biodiesel industries. 
1,4-Butanediol (BDO) 
BDO is used industrially as a solvent and serves as a raw material for a range of important chemicals 
including polymers polybutylene terephthalate (PBT), polybutylene succinate (PBS) and tetrahydrofuran 
(THF). BDO also acts as precursor to a number of specialty chemicals used as solvents or as raw 
materials in pharmaceuticals and agrochemicals. 
1,4-butanediol (BDO) is a bulk product that is currently being produced in large volumes from 
petrochemical raw materials in various ways (e.g. from petrochemical maleic anhydride). Various large 
companies and consortiums are working on the development and upscaling of bio-based BDO production. 
Different bio-based routes have been developed: from glucose, xylose, sucrose and biomass-derived mixed 
sugar streams Alternatively, BDO can be obtained from 4-hydroxybutyrate or from succinic acid. 
 
  
polymers that are outside the initial list, like polyesters, polyethers and their derivatives, 
among others. Some companies indicated that they produce or are planning to produce 
polymers that are not indicated in the provided list (both derived from natural polymers 
and from monomers), but they did not specify the name of the products. 
 
Table A20: Responses distribution about the production of bio-based polymers 
Bio-based polymers (derived from  Total companies 
indicating the 
product as current 
or expected 
New 
companies 
entering 
the market 
in 2020 
Starch polymers, inc. composites 7 3 
Cellulose ether 2 1 
Cellulose ester, inc. cellulose acetates 1 0 
Microfibrillated cellulose 1 0 
Other (unspecified) 5 4 
   
Bio-based polymers (derived from monomers) Total companies 
indicating the 
product as current 
or expected 
New 
companies 
entering 
the market 
in 2020 
Polyhydroyalkanoates (PHAs), inc. PHB 5 3 
Polylactic acid (PLA) 5 2 
Polybutylene succinate (PBS) 4 4 
Polyamides 4 0 
Polyesters 3 0 
Polyethylene furanoate (PEF) 2 1 
Polyurethane (PUR) 1 1 
Polybutyrate (PBAT) 1 1 
Polyethylene (PE) 1 1 
Polyvinyl chloride (PVC) 1 1 
Polypropylene (PP) 1 1 
Polyethylene terephthalate (PET) 1 1 
Polybutylene terephthalate (PBT) 1 0 
Polyvinyl acetate (PVA) 1 0 
Polystyrene (PS) 1 0 
Polymethyl methacrylate (PMMA) 1 0 
Schizophyllan 1 0 
Co-polyols (capa-lactide)  1 0 
Polycarbonates (PC) 0 0 
 Formulated polyesters 
 Polyester resins 
 Polyether block amide (PEBAX) 
 Polyester-polyols 
 TPC-ET: (thermo-plastic polyester elastomer) 
 PTT (polytrimethyleneterephtalate) 
 Polyesters 
Source: EU bio-based industries survey. 
 
  
  
BOX3 – Promising Bio-based Polymers 
 
Starch polymers, inc. composites 
Plasticised starch is essentially starch that has been modified by the addition of plasticisers (or other 
plasticising additives) to enable processing. Thermoplastic starch is plasticised starch that has been 
processed (using heat/pressure) to completely destroy the crystalline structure of starch, to form an 
amorphous thermoplastic starch – this typically involves an irreversible order-disorder transition called 
gelatinisation. 
Polyhydroyalkanoates (PHAs), inc. PHB 
Polyhydroxyalkanoates or PHAs are a class of linear polyesters produced in nature by the direct bacterial 
fermentation of sugar or lipids. These plastics are biodegradable (suitable for home composting) and can 
either be thermoplastic or elastomeric materials. More than 150 different monomers can be combined 
within this family to give materials with extremely different properties. PHAs are increasingly used for 
blending, for instance to increase the impact resistance of PLA. Polyhydroxybutirate (PHB) and 
polyhydroxyvalerate (PHVB) are common types of PHAs seen in nature. 
Polylactic acid (PLA) 
Polylactic acid, or polylactide, is a thermoplastic polyester. It is suitable for packaging materials, 
insulation foam, car parts, fibres (textile and non-woven), and as a feedstock for 3D printers. 
PLA is a fully bio-based plastic, derived from corn starch (in the US), tapioca roots, chips or starch (in 
Asia) or sugarcane (in the rest of the world). Production occurs via fermentation of sugars to lactic acid, 
then dehydratation to form lactide, which can then be polymerized to make PLA, either cast, injection 
molded or spun. PLA is biodegradable/compostable under certain circumstances. 
Polybutylene succinate (PBS) 
PBS is a relatively new thermoplastic polyester. The material is biodegradable and used for blending with 
starch polymers to improve properties. PBS is most commonly manufactured via the esterification of 
succinic acid and butane-1,4-diol. PBS has previously been of fossil origin, but developments to produce it 
from bio-based succinic acid and bio-based BDO are on their way. PBS has a properties profile similar to 
that of polypropylene (PP), thus the potential application area is enormous. It could be processed into 
films, bags or boxes (for food and cosmetic packaging). Other applications could be found as disposable 
products such as tableware, agricultural mulching films or delayed release materials for pesticide and 
fertilizer, drug encapsulation systems, medical implants, fishing nets, and other sectors. 
 
  
Composites 
Bio-based composites, especially natural fibres plastic composites, have been indicated 
by several companies in the survey, in particular plastic composites with wood (WPC) 
and other unspecified natural fibres, which are planned to be produced by two and six 
companies respectively by 2020 (Table A21 and Box 4). Four respondents indicated that 
they are producing bio-based composites beyond the list provided, but they did not 
specify which ones. 
Table A21: Responses distribution about the production of bio-based composites 
Bio-based composites Total companies 
indicating the 
product as 
current or 
expected 
New 
companies 
entering the 
market in 
2020 
Other natural fibre reinforced 
plastics 
8 6 
Wood-plastic composites (WPC) 6 2 
Cork reinforced plastics 1 0 
Other (unspecified) 4 0 
Source: EU bio-based industries survey. 
 
 
 
  
BOX4 – Bio-based composites 
Natural fibre reinforced plastics 
Natural fibre plastic composites (NFPCs) are a potential environmentally friendly and cost-effective 
alternative to synthetic fibre reinforced composites. NFPC may contain non cellulose-based fibre fillers 
such as pulp fibres, peanut hulls, bamboo, straw and digestate. 
Wood-plastic composites (WPC) 
Wood-plastic composites (WPC) are composite materials made of wood/fibre/wood flour and virgin or 
recycled thermoplastic(s) including HDPE, LDPE, PVC, PP, ABS, PS and PLA. Polyethylene based WPCs are 
by far the most common.  
The main known use of WPC is as building materials, in particular in outdoor deck floors , railings, fences,  
park benches, window and door frames, among many other possibilities. 
 
 
  
Surfactants 
Several surfactant products were indicated by the survey respondents (Table A22). In 
particular polymeric surfactants, fatty alcohol ethoxylates/esthers and esther quats were 
indicated by at least four different companies. Polymeric surfactants and glycolipids are 
also considered as promising since two companies have indicated that they plan to enter 
the market by 2020. These products are described in Box 5. 
Several bio-based surfactants have been indicated by respondents outside the list 
provided. They include Fatty acid ethoxilates and esters, Fatty ester ethoxilates, 
Alkylquats, Sodium alkoxylates and Metallic salts. 
Table A22: Responses distribution about the production of bio-based surfactants 
Bio-based products - surfactants Total 
companies 
indicating the 
product as 
current or 
expected 
New 
companies 
entering the 
market in 2020 
Polymeric surfactants 9 2 
Fatty alcohol ethoxylates/ethers 5 0 
Ester quats 4 0 
Alkyl polyglucosides 3 1 
Fatty alcohol ether sulfates 3 0 
Fatty alcohol sulfates 3 0 
Glycolipids, inc. sophorolipids 2 2 
Amphoteric surfactants (inc. 
betaines) 
2 0 
Metallic soaps 2 0 
Amphoacetates 1 0 
Lipopeptides and digopeptites 0 0 
Other 5 0 
 Fatty acid ethoxilates 
 Alkylquats 
 Sodium alkoxylates 
 Fatty alcohol esters 
 Fatty ester ethoxilates 
 Metallic salts of fatty acids and fatty esters 
Source: EU bio-based industries survey. 
 
  
  
BOX5 – Promising bio-based surfactants 
Polymeric surfactants 
Polymeric surfactants refer to macromolecules containing both hydrophilic and hydrophobic parts. This 
definition also includes amphiphilic polymers, micellar polymers, hydrophobically modified water-soluble 
polymers, associative polymers, and related terms. Certain proteins (e.g. casein in milk) and 
polysaccharides like emulsan and chitosan are also examples of polymeric surfactants. 
It is usually very difficult to isolate polymeric surfactants from natural sources, and their structures and 
compositions can vary depending on the source; therefore, most of the systems studied and reported in 
the literature are synthetic.  
They are demonstrating actual and potential applications in several fields including (mini)emulsion 
polymerizations, coatings, biotechnology, nanotechnology, medicine, pharmacology, cosmetics, 
agriculture, water purification, electronic, optoelectronic, and enhanced oil recovery 
(http://pubs.acs.org/doi/pdf/10.1021/cr500129h). 
Fatty alcohol ethoxylates/ethers 
Ethoxylation is the process by which ethylene oxide is added to a fatty acid alcohol to create detergent 
properties in a surfactant. Alcohol ethoxylates (AE) and alcohol ethoxysulfunates (AES) are surfactants 
found in products such as laundry detergents, surface cleaners, cosmetics and for use in agriculture, 
textiles and paint. In industrial ethoxylation, alcohol is heat & pressure treated with ethylene oxide, using 
potassium hydroxide (KOH) as a catalyst. Traditionally the alcohols were obtained by hydrogentation of 
fatty acids, but currently most are "oxo alcohols", obtained via hydroformylation. 
Alkyl ether sulfates result from the sulfation of an ethoxylated fatty alcohol. AES found in consumer 
products generally are linear alcohols. A common example is sodium lauryl ether sulfate (SLES), an 
anionic detergent and surfactant found in many personal care products (soaps, shampoos, toothpaste, 
etc.), as well as industrial detergents. 
Ester quats 
Esterquats, which are quaternary ammonium compounds having two long (C16-C18) fatty acid chains 
with 2 weak ester linkages, represent a new generation of fabric softening agents, having replaced the 
dialkyldimethylammonium salts. This new generation of fabric softening agents combines a good 
environmental profile with the structural features required for an effective fabric conditioner. 
https://www.jstage.jst.go.jp/article/jos/56/6/56_6_269/_article  
Glycolipids, inc. sophorolipids 
The major and most widely used biosurfactants in cosmetics and personal care products are glycolipids 
because of their physic-chemical properties, biological activities, biocompatibility and biodegradability, 
and are used as multifunctional ingredients in the formulation of cosmetics. Potential glycolipid 
biosurfactants employed in the cosmetics industry are sophorolipids, rhamnolipids and 
mannosylerythritol lipids. A sophorolipid is a surface-active glycolipid compound that can be synthesized 
by certain yeast species. http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2494.2009.00493.x/epdf   
 
  
Other oleochemicals (Solvents, Binders, Plasticizers and Paints&Coatings) 
Among the oleochemicals described in this section, the products indicated most often by 
respondents are paint additives (ten companies indicated them), and certain types of 
lubricants: Mould release agents, Hydraulic fluids and Chain & bearing lubricants (all 
described in Box 6). However, not many new companies are entering the market by 
2020, according to the responses obtained: only two companies will start producing 
paint additives and one company will start producing the plasticizers furanoate esters by 
2020. Some respondents also indicated that they produce oleochemical products outside 
the list provided, but they did not specify the exact products. 
Table 23: Responses distribution about the production of bio-based Solvents, Binders, Plasticizers 
and Paints&Coatings 
 Total companies 
indicating the 
product as 
current or 
expected 
New companies 
entering the 
market in 2020 
Bio-based solvents 
Methyl levulinate 1 0 
Other (unspecified) 3 0 
Bio-based binders   
Adhesives (inc. lignin-based) 2 0 
Colloid binders 1 0 
Pentaerytrithol 1 0 
Modified starches 1 0 
Sugar-based binders 1 0 
Others (unspecified) 2 0 
Bio-based plasticisers   
Furanoate esters 1 1 
Phthalate esters 1 0 
Epoxidized Soya bean oil  1 0 
Isosorbide diester 1 0 
Other (unspecified) 1 0 
Bio-based paints/coatings   
Paint additives 10 2 
Resins / Alkyd resins 2 0 
Printing colours 1 1 
Hybrid polymer coatings (mixtures of 
natural and synthetic polymers) 
1 0 
Rheology additives 1 0 
Other (unspecified) 1 0 
Bio-based lubricants   
Mould release agents 5 0 
Hydraulic fluids 5 0 
Chain & bearing lubricants 4 0 
Additives / Raw materials for 
lubricants 
2 0 
Metal working fluids 1 0 
Metalic stearates 1 0 
Source: EU bio-based industries survey. 
 
  
 
  
BOX6 – Promising bio-based oleochemicals 
Paint additives: 
Paint can have a wide variety of additives, usually added in small amounts, yet providing a significant 
effect on the product. Examples include additives to modify surface tension, improve flow properties, 
finished appearance, wet edge, pigment stability, antifreeze properties, plus control foaming and 
skinning. Other types of additives include catalysts, thickeners, stabilizers, emulsifiers, texturizers, 
adhesion promoters, UV stabilizers, flatteners (de-glossing agents), biocides to fight bacterial growth. 
Mould release agents 
Some release agents, also known as de-moulding agent, form oil, parting agent or form releaser, are 
substances used in moulding and casting that aid in the separation of a mould from the material being 
moulded and reduce imperfections in the moulded surface. This lubricant category do not to cover rubber 
release agents, which are silicone based. 
Hydraulic fluids 
Hydraulic fluids can contain a wide range of chemical compounds, including: oils, butanol, esters (e.g. 
phthalates, like DEHP, and adipates, like bis(2-ethylhexyl)adipate), polyalkylene glycols (PAG), 
organiphosphate (e.g. tributylphosphate), silicones, alkylated aromatic hydrocarbons, polyalphaolefins 
(PAO) (e.g. polyisobutenes), corrosion inhibitors (incl. acid scavengers), anti-erosion additives, etc. 
Chain & bearing lubricants 
Typically lubricants contain 90% base oil (most often petroleum fractions, called mineral oils) and less 
than 10% additives. Vegetable oils or synthetic liquids such as hydrogenated polyolefins, esters, silicones, 
fluorocarbons and many others are sometimes used as base oils. Additives deliver reduced friction and 
wear, increased viscosity, improved viscosity index, resistance to corrosion and oxidation, aging or 
contamination, etc. 
 
  
Other bio-based products 
The bio-based products that are not included in the previous categories constitute a 
heterogeneous group (Table A24), in which the ones that are indicated by most 
companies are fatty acid esters, ethylene glycol, Hydroxymethyl-furfural (HMF) and 
ethylene. Of those, a promising future bio-based product is HMF, which is not currently 
produced by any of the respondents, but four companies are planning to start its 
production by 2020. Also, three companies will start the production of ethylene glycol 
and two of ethylene by 2020. Among the products indicated by respondets beyond the 
list provided are agents for oilfield and dishwashing applications, Carbon Nanotubes and 
additives for Polyvinyl chloride (PVC). 
Table A24: Responses distribution about the production of other bio-based products 
Other bio-based products Total 
companies 
indicating 
the product 
as current 
or 
expected 
New 
companies 
entering 
the market 
in 2020 
Fatty acid esters (inc. FAGE and 
cosmetics) 
6 1 
Ethylene glycol 5 3 
Hydroxymethyl-furfural (HMF) 4 4 
Ethylene 4 2 
Fatty amines 4 0 
Isosorbide 2 0 
Isoprene 1 1 
Farnesene 1 1 
Para-xylene 1 1 
Limonene 1 1 
Epichlorohydrin 1 0 
Chelating agents 1 0 
Other polymer additives (curing 
agents) 
1 0 
Lignosulphonates 1 0 
Acetaldehyde 1 0 
Ethyl acetate  1 0 
Fatty acid amide 1 0 
Acetone 0 0 
Other 4 0 
 Agents for oilfield and dishwashing applications 
 Carbon Nanotubes produced from ethanol 
 Other polymer additives (additives for PVC) 
Source: EU bio-based industries survey. 
 
  
 
 
BOX7 – Other promising bio-based products 
Fatty acid esters 
Fatty acid esters (FAEs) are a type of ester that results from the combination of a fatty acid with an 
alcohol. The alcohol can be for example methanol, giving rise to fatty acid methyl esters or FAME, used to 
produce detergents and biodiesel, or ethanol, giving rise to fatty acid ethyl esters (FAEE).When the 
alcohol component is glycerol, the fatty acid esters produced can be monoglycerides, diglycerides, or 
triglycerides. Biodiesels are typically fatty acid esters produced by the transesterification of vegetable 
fats and oils which results in the replacement of the glycerol component with a different alcohol. Fatty 
acid glycerol formal esters (FAGE) are obtained from oils (vegetable, animal or waste oils) and glycerol 
and can be used as a blending component in diesel fuels. 
Hydroxymethyl-furfural (HMF) 
HMF is a very important building block for a wide range of applications, including polymers, fine 
chemicals and fuels. HMF can be converted to a range of furan derivatives, like FDCA. HMF can be 
converted to 2,5-dimethylfuran (DMF), which is a liquid biofuel with a greater energy content bioethanol. 
Among others, HMF can also be converted to gamma-valerolactone (GVL) for the perfume and flavor 
industries and 2,5-bis(hydroxymethyl)furan for the manufacture of polyurethane foams and polyesters. 
HMF is produced from carbohydrates such as fructose, glucose, sucrose, cellulose and inulin. The most 
common route is dehydration of fructose or other hexoses. Different solvent systems have been 
researched to obtain an efficient HMF production but significant challenges still remain in transferring it 
to an industrial scale. 
Ethylene 
Ethylene is produced in the petrochemical industry by steam cracking, with worldwide production of 127 
million tonnes. It widely used in chemical industry, for polymerisation (into polyethylene) a major use, as 
well as oxidation to ethylene dioxide, halogenation (e.g. to ethylene dichloride for PVC), alkylation to 
ethylbenzene (precursor to styrene), and hydration to ethanol. Ethylene is also as important natural 
plant hormone, used in agriculture to force the ripening of fruits. 
Ethylene glycol 
Ethylene glycol is produced from ethylene (ethane), via the intermediate ethylene oxide. Ethylene glycol 
is primarily used as raw material in the manufacture of polyester fibers and fabric industry, and 
polyethylene terephthalate resins (PET) used in bottling. A small percent is also used in other 
applications such as antifreeze formulations and other products. 
Fatty amines 
Fatty amines are oleochemical compounds in which an amine is attached to a hydrocarbon chain of eight 
or more carbon atoms in length, more commonly C12-C18 hydrocarbons derived from fatty acids. 
Commercially important fatty amines include coco amine, oleylamine, tallow amine, and soya amine. 
Some applications of these compounds are in fabric softeners, flotation agents, corrosion inhibitors, 
dispersants and emulsifiers. They are the basis for a variety of cosmetic formulations. 
Fatty amines are commonly prepared from fatty acids that can derive from vegetable oils. The overall 
reaction is sometimes referred to as the Nitrile Process and begins with a reaction between the fatty acid 
and ammonia at high temperature and in the presence of a metal oxide catalyst. 
 
  
 
 
 
BOX1 – Promising Bio-based Organic Acids 
 
Succinic Acid 
Succinic acid and its derivatives are most widely used as food or pharmaceutical ingredients. Succinic acid 
also has a wide range of industrial applications, still limited by its price, like the manufacture of the 
biodegradable polymer polybutylene succinate (PBS). Succinic acid could also be used as replacement for 
maleic anhydride and precursor for 1,4 butanediol (BDO), tertahydrofuran (THF) and γ-butyrolactone 
(GBL). 
Succinic acid is conventionally produced from butane or benzene. Bio-based succinic acid can be produced 
by fermenting carbohydrate or glycerol using engineered bacteria or yeast. 
2,5-Furandicarboxylic acid - FDCA 
FDCA is showing a big potential as a replacement of several petroleum based platform chemicals, e.g. 
terephthalic acid, adipic acid and other important di-acids by polymerization. FDCA has also strong 
potential to be used in the production of solvents, especially novel solvents. 
FDCA is a furan that can be synthesized from the oxidation of 2,5-disubstituted furans or the catalytic 
conversion of various furan derivatives. A bio-based route is the oxidative dehydration of glucose by using 
either oxygen or electrochemistry. FDCA can also be produced by the oxidation of 5-
hydroxymethylfurfural (HMF), an intermediate in the production of levulinic acid from hexose sugars. 
Levulinic Acid 
Presently, levulinic acid finds applications in pharmaceuticals, pesticides, cosmetics, food additives, 
cigarettes and minor use in nylons, synthetic rubbers and plastics. It has been identified as critical 
building block to act as precursor to chemicals including fuel additives, pesticides and certain biofuels.  
Levulinic acid is usually obtained by the hydrolysis of sucrose to glucose, isomerisation to fructose, then 
dehydration of fructose to hydroxynethylfurfural (HMF), followed by hydrolysis resulting in levulinic acid 
with formic acid as a by-product. 
Adipic Acid 
The great majority of adipic acid is used as monomer for the production of nylon by a polycondensation 
reaction forming 6,6-nylon. Other major applications also involve the production of Polyurethane and its 
esters. Other uses of adipic acid can be found in the field of medicine, for drug delivery, and of food 
ingredients. 
Several fossil-based processes for the production of adipic acid are known, including biosynthesis of adipic 
acid from cyclohexanol and cyclohexane-based processes among others. One process described in 2006 
that involves a biomass substrate is the biosynthesis of cis,cis-muconic acid by fermentation of glucose, 
followed by catalytic hydrogenation to adipic acid. Since then several companies have claimed different 
processes for adipic acid from raw renewable materials. 
Furfural 
Furfural is an important chemical solvent and chemical building block. Hydrogentation of furfural 
provides furfuryl aolcohol (FA), which is a useful chemical intermediate and which may be further 
hydrogenated to tretrahydrofurfuryl alcohol (THFA). It is also used to make other furan chemicals, such 
as furoic acid (via oxidation) and furan (via decarboxylation). 
Furan is a colourless oily liquid derived from a variety of agricultural byproducts, including corncobs, oat, 
wheat bran and sawdust. 
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